Emeritus Professor of Medicine, Physiology and Biophysics
School of Medicine

Former Chief, Division of Nephrology and Hypertension and former Chairman of Department of Medicine, Medicine
School of Medicine

My research has been focused on oxidative stress, inflammation, microbial disbiosis, NO metabolism & mechanisms of lipid disorders in chronic renaldisease & proteinuria.

Elected Faculty Member, Alpha Omega Alpha (AOA), Honor Medical Society, 1976

Voted Outstanding Teacher, 1975, 1976, 1978,1980, 1982

Golden Apple Award, 1977

The Kaiser-Permanente Award Presented by UCI Foundation, 1977

President, American Paraplegia Society, 1991-1993

The Best Doctors in America: Pacific Region, 1996- 2011

The Best Doctors in America, 1998-2011

Chair of Faculty, UCI College of Medicine, 2000-2002

Master, American College of Physicians, 1999

UCI Lauds and Laurels Award for Fculty Achievement, 1999

Fellow, Council for High Blood Pressure Research, 2000

Fellow, American Heart Association, 2001

Chancellor’s Award for Excellence in Fostering Undergraduate Research, UCI 2002

Spirit of Nephrology Award, National Kidney Foundation 2002

Donald Munro Award, American Paraplegia Society 2002

America’s Best Nephrology Programs (N.D.Vaziri, MD, Director) US News and
World Report, 2002, 2011

Outstanding Health Science Researcher Award (Athalie Clarke), UC Irvine 2003

Distinguished Lectureship Award, Korean Society of Nephrology, 2004

President, Western Association of Physicians, 2006-2007

America’s top physicians, Cosumers Research Council of America, 2004-20013

Presidential lectureship, Canadian Hypertension Society, 2006

Distinguished Service award, Western Association of Physicians, 2007

Promoted to Professor, above scale, UC Irvine, 2007

Councilor, International Society of Uremia Research and Toxicity (2009-2015)

Distinguished Lectureship Award, Romanian Society of Nephrology, 2009

Laureate Award, Americal college of Physicians, 2010

Certificate of Recognition for academic achievements, California Representative Assembly 2010

The Clinical Translational Scientist of the Year Award for Applied Translational Science , 2014

The distinguished Emeriti Award presented by UCI Emeriti Association, 2016


Editorial Boards:

Nephrology Dialysis Transplantation, Editor, Basic Science in Nephrology section, 2011-

Kidney International, Editorial Board, 2000-2013

International J of Artificial Organs, Section editor, 1982-present

Journal Clinical & Experimental Hypertension, Editorial Board, 2010- present

Journal of Renal Nutrition, Editorial Board, 2005-2011

The Journal of Spinal Cord Medicine, Senior Associate Editor, 1991-2005

Journal of Spinal Cord Medicine, Editor Emeritus, 2006-present

Journal of Spinal Cord Medicine, Section Editor, 1991-2005

Advances in Renal Replacement Therapy, Editorial Board, 1999-2002

Nephron, Editorial Board, 1999-2002

ASAIO Journal, Editorial Board, 1995-1997

American J of Nephrology, Editorial Board 1998-2002

Chief, Division of Nephrology and Hypertension, University of California, Irvine, 1977-2011

Chairman, Department of Medicine, University of California, Irvine, March, 1994-November, 1998

Professor of Medicine, University of California, Irvine, 1982 Present

Professor of Physiology and Biophysics University of California, Irvine, 2001 - Present

Professor, Step VII, 2000

Professor, Step IX, 2003

Chair of Faculty, UCI College of Medicine, 2000-2002

Vice Chairman, Department of Medicine, University of California, Irvine, 1982-1994

Director, Hemodialysis Unit, University of California Irvine Medical Center, Orange, California, 1977-1994

Associate Professor of Medicine, School of Medicine, University of California, Irvine, 1979 1982

Assistant Professor of Medicine, School of Medicine, University of California, Irvine, 1974 1979
Emeritus professor of Medicine and Physiology 2011-present

INVITED BOOK CHAPTERS, REVIEWS AND EDITORIALS

1. Vaziri, N.D.: Peritoneal dialysis. Critical Care Update 5-23, 1975.

2. Vaziri, N.D., and McMahon, R.: Insight into short and long-term hemodialysis. In: Mosby's Comprehensive Review of Critical Care. St. Louis: The C.V. Mosby Company, 1976.

3. Vaziri, N.D.: Complications of hemodialysis and their management. In: Mosby's Comprehensive Review of Critical Care. St. Louis: The C.V. Mosby Company, 1976.

4. Vaziri, N.D.: Principles of peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care. St. Louis: The C.V. Mosby Company, 1976.

5. Vaziri, N.D.: Long-term peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care. St. Louis: The C.V. Mosby Company, 1976.

6. Vaziri, N.D.: Malignant hypertension. Critical Care Update 3(1):5-17, 1976.

7. Vaziri, N.D.: Concepts in hemodialysis. Critical Care Update 3(3):5-17, 1976.

8. Vaziri, N.D., Mirahmadi, K.: New concepts in disorders of fluids and electrolytes. Critical Care Update 6:5-15, 1977.

9. Vaziri, N.D.: Nephrologic emergencies, emergencies related to hemodialysis and hypertensive crisis. In: Emergency Care: Principles and Practices for the EMT-Paramedic. Reston, Virginia: Reston Publishing Company, Inc., 1979.

10. Vaziri, N.D.: Principles of hemodialysis. In: Mosby's Comprehensive Review of Critical Care. St. Louis: The C.V. Mosby Company, 1980.

11. Vaziri, N.D., Mirahmadi, K., and Robinson, M.S.: Hemoperfusion and vascular access. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

12. Vaziri, N.D.: Complications in hemodialysis and their management. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

13. Vaziri, N.D.: Principles of peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

14. Vaziri, N.D.: Maintenance peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

15. Vaziri, N.D.: Accelerated or malignant hypertension. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

16. Vaziri, N.D., and Madani, G.: Pediatric hypertension. In: Mosby's Comprehensive Review of Critical Care (2nd Edition). St. Louis: The C.V. Mosby Company, 1980.

17. Mirahmadi, K., and Vaziri, N.D.: Value of serum ferritin determination in hemodialysis patients. Int. J. Artif. Organs 3(6):318-319, 1980.

18. Vaziri, N.D.: Reducing blood loss in dialysis patients. Int. J. Artif. Organs 4(2):57-58, 1981.

19. Warner, A., and Vaziri, N.D.: Treatment of lactic acidosis. Southern Med. Journal 74:841-847, 1981.

20. Zetin, M., Plummer, M., Vaziri, N.D., and Cramer, M.: Locus of control and adjustment of chronic hemodialysis. Journal of Dialysis 5(3):319-334, 1981.

21. Saiki, J., Vaziri, N.D., Barton, C.: Perinephric and intranephric abscesses: A review of the literature. Western J. Medicine 136:95-102, 1982.

22. Vaziri, N.D.: Dialysis-induced hypoxemia. Int. J. Artif. Organs 5(1):8-10, 1982.

23. Vaziri, N.D.: Acquired renal cyctic disease in dialysis patients. Int. J. Artif. Organs 5(6):336-338, 1982.

24. Vaziri, N.D.: Nephrotic syndrome and coagulation and fibrinolytic abnormalities. Amer. J. Nephrology 3:1-6, 1983.

25. Zetin, M., Vaziri, N.D., Bergstrom, K.: Attitudes towards death in hemodialysis patients. Arch. Foundation of Thanatol. 211-218, 1983.

26. Vaziri, N.D., and Saiki, J.: Nephrologic emergencies. In: Emergency Care: Principles and Practices. Reston, Virginia: The Reston Publishing Company, 1984.

27. Vaziri, N.D.: Malignant or accelerated hypertension. West. J. Med. 140:575-582, 1984.

28. Darwish, R., and Vaziri, N.D.: Role of immunologic mechanisms in tubulointerstitial nephropathies. South. Med. J. 77:351-359, 1984.

29. Vaziri, N.D.: Chronic hemodialysis in end-stage renal disease associated with paraplegia. Int. J. Artif. Organs 7(3):111-114, 1984.

30. Pahl, M.V., Vaziri, N.D.: Maintenance hemodialysis in end-stage lupus nephritis. Int. J. Artif. Organs 7(5):243-244, 1984.

31. Elias, A.N., Vaziri, N.D.: Thyroid dysfunction in end-stage renal disease. Int. J. Artif. Organs 7(6):311-314, 1984.

32. Barton, C.H., Vaziri, N.D.: Dialysis and transplantation in multiple myeloma. Int. J. Artif. Organs 7(6):317-318, 1984.

33. Massry, S.G., and Vaziri, N.D.: Renal vein thrombosis. In: Textbook of Nephrology. Baltimore: Williams-Wilkins Co., 1985.

34. Vaziri, N.D.: Hemodialysis. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

35. Vaziri, N.D.: Acute and chronic consequence of hemodialysis. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

36. Vaziri, N.D., Mirahmadi, M.K., Robinson,M.A.: Hemoperfusion and vascular access. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

37. Vaziri, N.D.: Malignant hypertension. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

38. Vaziri, N.D.: Long-term peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

39. Vaziri, N.D.: Principles of peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

40. Vaziri, N.D., Madani, G., Barton, C.H.: Childhood hypertension. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

41. Vaziri, N.D.: Acute peritoneal dialysis. In: Mosby's Comprehensive Review of Critical Care (3rd Edition). St. Louis: The C.V. Mosby Company, 1985.

42. Elias, A.N., Vaziri, N.D.: Plasma catecholamines in chronic renal disease. Int. J. Artif. Organs 8(5):243-244, 1985.

43. Barton, C.H., Vaziri, N.D.: Cyclosporine nephrotoxicity. Int. J. Artif. Organs 8(6):291-296, 1985.

44. Vaziri, N.D.: Anemia in ESRD patients. In: Dialysis Therapy. Philadelphia: Hanley and Belfus, Inc., 1986.

45. Vaziri, N.D.: Renal vein thrombosis. In: Current Therapy in Nephrology and Hypertension (2nd Edition). Philadelphia: B.C. Decker, 1987.

46. Vaziri, N.D.: Is contact activation of coagulation system involved in the genesis of the first-use syndrome. Artif. Organs 11(2):163-164, 1987.

47. Vaziri, N.D., Kim, I.: Serum enzyme levels. In: Handbook of Dialysis. Boston: Little, Brown and Company, 1988.

48. Pahl , M.V., Vaziri, N.D.: Cancer in end-stage renal disease. In: Handbook of Dialysis. Boston: Little, Brown and Company, 1988.

49. Fairshter, R.D., Vaziri, N.D.: Lungs and pleura in patients with pulmonary disease. In: Handbook of Dialysis. Boston: Little, Brown and Company, 1988.

50. Vaziri, N.D., Kaupke, C.J.: Biochemical investigations of urine. In: Textbook of Nephrology. Baltimore: Williams-Wilkins Co., 1988.

51. Vaziri, N.D.: Renal insufficiency in patients with spinal cord injury. In: Comprehensive Management of the Spinal Cord Injured Patient. New York: Grune and Stratton, Inc., 1989.

52. Massry, S.G., Vaziri, N.D.: Renal vein thrombosis. In: Textbook of Nephrology. Baltimore: Williams-Wilkins Co., 1989.

53. Meshkinpour, H., Vaziri, N.D.: Interrelationship of renal and pancreatic disorders. Dig. Dis. 7:221-229, 1989.

54. Gwinup, G., Elias, A.N., Vaziri, N.D.: A case for oral insulin therapy in the prevention of diabetic micro- and macroangiopathy. Int. J. Artif. Organs 13(7):393-395, 1990.

55. Elias, A.N., Vaziri, N.D.: Gonadotropin secretion in chronic renal failure. Int. J. Artif. Organs 13(8):461-463, 1990.

56. Vaziri, N.D.: Renal insufficiency in patients with spinal cord injury. In: The Spinal Cord Injured Patient: Comprehensive Management. Philadelphia: W. B. Saunders Company, 1991.

57. Pahl, M.V., Vaziri, N.D.: Gastroduodenal abnormalities in uremia. Int. J. Artif. Organs 14:10-12, 1991.

58. Tennyson, T.E, Jennison, J.H., Vaziri, N.D.: Dialysis staff attitudes toward providing end-stage care. Loss, Grief & Care 5:151-160, 1991.

59. Kaupke, C.J., Vaziri, N.D.: Pleural complications in end-stage renal disease. Seminars in Dialysis 4(3):189-197, 1991.

60. Vaziri, N.D., Barton, C.H.: Renal vein thrombosis. In: Current Therapy in Nephrology and Hypertension (3rd Edition). Philadelphia: B.C. Decker, 1992.

61. Kaupke, C.J., Vaziri, N.D.: Nutritional implications of therapy with recombinant human erythropoietin in dialysis patients. Seminars in Dialysis 5:254-256, 1992.

62. Ing, T.S., Zhou, X.J., Yu, A.W., Vaziri, N.D.: Lactate-containing versus bicarbonate-containing peritoneal dialysis solutions. Peritoneal Dialysis Int. 18:276-277, 1992.

63. Vaziri, N.D., Kim, I.: Serum enzyme levels. In: Handbook of Dialysis (2nd Edition). Boston: Little, Brown and Company, 1993.

64. Kaupke, C.J., Vaziri, N.D.: Lungs and pleura. In: Handbook of Dialysis. Boston: Little, Brown and Company, 1993.

65. Pahl, M.V., Vaziri, N.D.: Cancer in end-stage renal disease. In: Handbook of Dialysis. Boston: Little Brown and Company, 1993.

66. Vaziri, N.D.: Pathophysiology of end-stage renal disease in spinal cord injury. Mt. Sinai J. Med. 60(4):302-304, 1993.

67. Vaziri, N.D.: Endocrinological consequences of the nephrotic syndrome. Am. J. Nephrol. 13:360-364, 1993.

68. Hatch, M., Freel, R.W., Vaziri, N.D.: Mechanisms for bi-directional oxalate transport across the large intestine. In: Urolithiasis 2. New York: Plenum Press, 1994.

69. Massry, S.G., Vaziri, N.D.: Thromboembolic complications. In: Textbook of Nephrology (3rd Edition). Baltimore: Williams-Wilkins Co., 1994.

70. Vaziri, N.D., Kaupke, C.J.: Biochemical investigations of urine. In: Textbook of Nephrology (3rd Edition). Baltimore: Williams-Wilkins Co., 1994.

71. Kaupke, C.J., Vaziri, N.D.: Seizures in dialysis patients. Seminars in Dialysis 7:37-40, 1994.

72. Hatch, M., Vaziri, N.D.: Colonic absorption of oxalate is reduced by millimolar concentration of thiazides. In: Urolithiasis: Consensus and Controversies Proceedings, 1994.

73. Sassoon, C., Vaziri, N.D.: Respiratory alkalosis. In: Handbook of Acid-Base Disorders. Boston: Little Brown and Company, 1995.

74. Popli, S., Ing, T.S., Vaziri, N.D.: Cardiovascular consequences of rapid hemodialysis. In: Vascular Access Principles and Practice (3rd Edition). St. Louis: Mosby, 1996.

75. Kaupke, C.J., Vaziri, N.D.: Renal complications of hepatitis C virus infection. West. J. Med. 164(5):442-443, 1996.

76. Vaziri, N.D., Barton, C.H.: Renal vein thrombosis. In: Current Therapy in Nephrology and Hypertension (4th Edition). Philadelphia: Mosby Inc., 1997/98.

77. Vaziri, N.D., Ateshkadi, A.: Effects of epoetin on vascular biology. Nephrol. Dial. Transplant. 14 (Suppl. 2):46-49, 1999.

78. Jacobs, C., Danielson, B.G., Eschbach, J.W., Goodkin, D.A., McMahon, L., Parfrey, P.S., Valderrabano, F., Vaziri, N.D.: Normalization of haemoglobin: Why not?. Nephrol. Dial. Transplant. 14:76-79, 1999.

79. Massry, S.G., Vaziri, N.D. Thromboembolic complications (Chapter 39) In: Textbook of Nephrology (4th Edition) Baltimore, Lippincott, Williams-Wilkins Co, 2000

80. Kaupke, C.J., Vaziri, N.D.: Biochemical investigations of urine. In: Textbook of Nephrology (4th Edition). Baltimore: Williams-Wilkins Co., 2000. (In press)

81. Barton, C.H., Vaziri, N.D.: Dyslipoproteinemia associated with chronic renal failure. In: Mehta and Lamiere Eds. Complications of Dialysis. New York: M. Dekker, Inc., 2001.

82. Vaziri, N.D.: Erythropoietin-induced hypertension. In: Harrison's Online Textbook of Medicine. Boston: McGraw-Hill, 1999.

83. Sangha, D.S., Vaziri, N.D., Ding, Y., Han, S., Alem, N., Chen, Y., and Purdy, R.E.: Simulated microgravity impairs vascular contractility: role of nitric oxide dependent vasodilator, mechanisms. Proc. Western Pharmacol. Soc. 42:5-7, 1999

84. Vaziri, N.D.: Vascular effects of erythropoietin and anemia correction. Seminars in Nephrology 20:356-363, 2000.

85. Vaziri, N.D.: Dissociation of the pressor and erythropoietic effects of erythropoietin. International Society of Nephrology 2000.

86. Vaziri, N.D., Pahl, M.V.: Hypertension and Epoetin use in dialysis patients. In: Dialysis Therapy (3rd Edition), (edited by Nissenson, A. and Fine, R.) publication date 2001.

87. Barton, C.H., Vaziri, N.D.: Renal insufficiency in spinal cord injured patients. The Spinal Cord Injured Patient, Bok Y. Lee and Lee E. Ostrander, Editors

88. Subach, R.A., Vaziri, N.D.: Epidemiology of chronic renal failure and guidelines for initiation of hemodialysis in: Vascular Access, Principles and Practice 4th edition, St. Louis, Mosby 2001.

89. Popli, S., Ing, T.S., Vaziri, N.D.: Cardiovascular consequences of rapid hemodialysis. : Vascular Access, Principles and Practice 4th edition, St. Louis, Mosby 2001.

90. Vaziri, N.D.: Cardiovascular effects of erythropoietin and anemia correction. Current Opinions in Nephrology and Hypertension 10:633-637, 2001

91. Foster, G.T., Vaziri, N.D., and Sassoon, C.: Respiratory Alkalosis. Respiratory Care 46:384-391, 2001

92. Barton, C.H. and Vaziri, N.D.: Renal insufficiency in patients with spinal cord injury. In: Spinal Cord Medicine (V.W. Lin, Editor) New York: Demos Medical Publishing, Inc. PP:263-298, 2002.

93. Vaziri, N.D.: Effect of chronic renal failure on nitric oxide metabolism. Am J Kidney Dis 38(4): Suppl 1:574-579, 2001

94. Vaziri, N.D. Effects of erythropoietin therapy and anemia correction on blood pressure and left ventricular function and structure. Advances in Cardiology (E. Braunwald, Editor), McGraw Hill, 2002.

95. Vaziri, N.D. Molecular mechanisms of lipid dysregulation in nephrotic syndrome. (Nephrology Forum) Kidney Int 63:1964-1976, 2003

96. Vaziri, N.D. Nitric oxide in microgravity-induced orthostatic intolerance: Relevance to spinal cord injury (Donald Monro, 2002 lecture, APS) J Spinal Cord Medicine 26:5-11, 2003.

97. Vaziri, N.D. Oxidative stress in chronic renal failure: Lessons learned from animal models. J Blood Purification 21: 327-349, 2003

98. Barth, J.D., Pahl, M.V., Zhang, L., Zongee, M., Vaziri, N.D. Sonographic reproducibility of a novel approach in the assessment of centralized access in end-stage renal disease. Int J Clin Practice 57: 360-363, 2003

99. Vaziri, N.D. Roles of oxidative stress and antioxidant therapy in chronic renal disease and hypertension. Current Opinion in Nephrology and Hypertension 13:93-99, 2004

100. Rodriquez-Itrube, B., Vaziri, N.D., Herrera, J., Johnson, R.J. Oxidative stress, renal infiltration of immune cells and salt-sensitive hypertension: All for one and one or all. Am J Physiol, Renal Physiol 286: F606-F616, 2004

101. Vaziri, N.D. Oxidative stress in Uremia. Nature, mechanisms and potential consequences. Seminars in Nephrology 24:469-473, 2004

102. Vaziri, N.D., Sica, D.: Lead-induced hypertension: Role of oxidative stress. Current Hypertension Reports 6:314-320, 2004

103. Vaziri, N.D. Mechanisms of altered lipid metabolism in nephritic syndrome. Korean J Nephrology 23:S435-S439, 2004

104. Vaziri, N.D. Role of oxidative stress in the pathogenesis of hypertension. Korean J Nephrology 23:S420-S424, 2004

105. Pahl, M.V., Culver, D., Vaziri, N.D. Boron and the kidney. J Renal Nutrition 15: 362-370, 2005

106. Vaziri, N.D. Dyslipidemia of chronic renal failure: The nature, mechanisms and potential consequences. Am J Physiol, Renal Physiol 290:262-272, 2006

107. Vaziri N.D., Moradi H. Mechanism of dyslipidemia of chronic renal failure. Hemodialysis Int 10: 1-7, 2006

108. Vaziri, N.D. Kayichian, D. Serum enzymes, Handbook of Dialysis. Boston, Little, Brown and Company.

109. Vaziri N.D. Lecithin: Cholesterol acyltransferase deficiency. Encyclopedic Reference of Molecular Mechanisms of Disease (F. Lang, Editor) Springer Publisher Heidelberg

110. Vaziri N.D. Cardiovascular effects of lead exposure. Revised Air Quality Standards (Publisher: U.S. Environmental Protection Agency)

111. Adams G., Vaziri N.D. Skeletal muscle dysfunction in chronic renal failure: Effect of exercise. Am J Physiol, Renal Physiol 290:753-791, 2006

112. Vaziri, N.D., Rodriguez-Itrube, B. Mechanisms of Disease: oxidative stress and inflammation in the patogenesis of hypertension. Nature, CP Nephrology 2:582-593, 2006

113. Vaziri, N.D and Pahl, M.V. Hypertension and Epoetin Use in Dialysis Patients. Handbook of Dialysis Therapy (4th Edition), (edited by Nissenson, A. and Fine, R.) publication date 2007.

114. Vaziri, N.D. Khan, Q. Interplay of Reactive Oxygen Species and Nitric Oxide in the Pathogenesis of Experimental Lead-Induced Hypertension. Clin Experimental Pharmacol Physiol 34:920-925, 2007

115. Vaziri, N.D. Potential risks of nitric oxide inhibition in spinal cord injury. J Spinal Cord Medicine 30: 3-4, 2007.

116. Rodriguez-Iturbe, B, Vaziri, N. D. Salt-sensitive hypertension: update on novel findings. NDT 22:992-995,2007.

117. Vaziri, N. D. Role of calcium, magnisium and heavy metals in hypertension. Hypertension Primer (In press)

118. Vaziri, N. D. Causal Link between oxidative stress, inflammation and hypertension IJKD 2:1-10, 2008

119. Zhou, X J., Rakheja, D., Yu, X., Saxena, R., Vaziri, N. D., Silva, F.G. The Aging Kidney. Kidney Int 74:710-720, 2008

120. Zhou, X J., Saxena, R., Liu, Z., Vaziri, N.D., Silva F.G. Renal senescence in 2008: Progress and Challenges. Int Urol Nephrol 40:823-839, 2008.

121. Vaziri, N.D. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol, Heart and Circ Physiol 295:H454-465, 2008

122. Vaziri, N. D. Anemia and anemia correction: surrogate markers or causes of mortality in chronic kidney disease. Nature CPN 4:436-445, 2008

123. Norris, K.C., Tareen, N., Martins, D., Vaziri, N.D. Implications of ethnicity for the treatment of hypertensive kidney disease, with an emphasis on African Americans Nat Clin Pract Nephrol 4:538-549: 2008

124. Vaziri, N.D. Managing Lipid Disorders in Chronic Kidney Disease: An Expert Commentary . Med Scape Int Med July, 2008

125. Vaziri ND, Gonick H. Cardiovascular effects of lead exposure Indian J Med Res 128: 426-435, 2008

126. Rodriguez-Iturbe B, Vaziri ND, Johnson RJ. Inflammation, angiotensin II, and hypertension. Hypertension 2008 52(5): 135-136

127. Vaziri, N. D., Zhou, X.J. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. NDT 24(4): 1082-1088, 2009

128. Saxena R, Yu X, Giraldo M, Arenas J, Vazquez M, Lu C, Vaziri N, Silva F, Zhou X. Renal transplantation in the elderly . Int Urol, Nephrol 41: 195-210, 2009

129. N.D. Vaziri, C.H. Barton, A. Kalthia. Epidemiology and pathophysiology of Chronic Renal Failure and Guidelines for Initiation of Hemodialysis. In Vascular Access: Principles and Practice, 5th edition, Samuel Eric Wilson (editor), Lippincott Williams & Wilkins (publisher)

130. Subhash Popli, Todd S. Ing, N.D. Vaziri. Cardiovascular Consequences of Rapid Hemodialysis In Vascular Access: Principles and Practice, 5th edition, Samuel Eric Wilson (editor), Lippincott Williams & Wilkins (publisher)

131. Vaziri ND. Thrombocytosis in Erythropoietin-Treated Dialysis Patients May Be Mediated by Erythropoietin Rather Than Iron Deficiency Am J Kidney Dis 53: 733-736, 2009

132. Vaziri ND. Causes of dysregulation of lipid metabolism in chronic renal failure. Seminars in Dialysis 22(6):644-51, 2009

133. Vaziri ND, Navab M, Fogelman AM. HDL metabolism and activity in chronic kidney disease. . Nature, Reviews Nephrology 6(5):287-96, 2010

134. Vaziri ND. Lipotoxicity and impaired HDL-mediated Reverse Cholesterol/lipid transport in Chronic Kidney Disease. J Renal Nutrition 20: S35–S43, 2010

135. Vaziri ND. Role of oxidative stress in the pathogenesis of erythropoietin-induced hypertension. Am J Hypertension 23(3):226-7, 2010

136. Vaziri ND. Book review, Silva’s Diagnostic Renal Pathology Kidney International (2009) doi:10.1038/ki.2009.392

137. Delfino RJ, Staimer N, Vaziri ND. Air pollution and circulating biomarkers of oxidative stress. Air Qual Atmos Health. 2011 Mar 1;4(1):37-52.

138. Navab DK, TchekmedyianV, Hama S, Hough G, Vakili L, Reddy ST, Navab M, Vaziri ND, Fogelman AM. Chronic inflammatory disorders and accelerated atherosclerosis: Chronic Kidney Disease. Current Pharmaceutical Design 17(1):17-20. 2011

139. Vaziri ND, Norris K. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purification 2011;31(1-3):189-96

140. Martins D, Vaziri ND, Norris K. Improving Hypertension Control: Adherence to Regimens. Handbook on Hypertension (Baliga R and Bakris G. editors) Oxford University Press 2011 (In press)

141. Van Buren P, Vaziri N D, Zhou XJ.. Iron overdose: a potential cause of adverse outcomes in randomizes trials of anemia correction in CKD. Int J Urol, Nephrol 44(2):499-507, 2012

142. Vaziri N D Potential role of recombinant erythropoietin and intravenous iron preparations in target vessel re-stenosis following coronary stint insertions in hemodialysis patients. Internal Medicine; 50(13):1449-50, 2011

143. Sinha-Hikim I, Sinha-Hikim AP, R Shen, Kim H, French SW, Vaziri ND, Crum A, Rajavashisth T, Norris KC. Oxidative stress and Health Disparities. J Health Care for the Poor and Underserved , 2011

144. Saxena R, Fenves A, Yu X, Vaziri ND,Silva FG. Zhou XJ. RENAL FUNCTION AND DISEASE IN THE AGING KIDNEY Diseases of the Kidney Tenth Edition Lippincott Wilkins and Williams

145. Vaziri ND, Pahl, MV, Crum A, Norris K. Effect of uremia on function and structure of immune system. J Renal Nutrition 22(1):149-56, 2012

146. Vaziri ND. Understanding Iron: Promoting its Safe Use in Patients with end-stage renal disease . Am J Kidney Disease. 61(6):992-1000, 2013

147. Nafar M, Sahraei, Salamzadeh, Samavati S, Vaziri ND. Oxidative Stress in Kidney Transplantation, Causes, Consequences, and Potential Treatment. IJKD 5(6):357-72, 2011.

148. Vaziri ND. Epidemic of iron overload in dialysis population caused by intravenous iron products: a plea for moderation. American J Medicine 125(10):951-2.2012

149. Epstein M, Vaziri ND. Role of statins in the management of dyslipidemia of chronic kidney disease; Current concepts and emerging treatment paradigms . Nature Reviews, Nephrol 8(4):214-23, 2012.

150. Ruiz S, Pergola PE, Zager RA, Vaziri ND. Targeting Nrf2 activation to ameliorate oxidative stress and inflammation in Chronic Kidney Disease. Kidney Int 83(6):1029-41, 2013.

151. Vaziri ND. Protective effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease. Diabetes 61(10):2400-2, 2012

152. Savaj S, Vaziri ND. An overview of recent advances in the pathogenesis and diagnosis of Preeclampsia. IJKD 6(5):334-8. 2012

153. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine - A major link to inflammation and uremic toxicity. Current Opinion in Nephrology & Hypertension 21(6):587-92, 2012

154. Vaziri ND, Norris KC. Reasons for the lack of salutary effects of cholesterol lowering interventions in ESRD populations. Blood Purification;35:31–36, 2013

155. Vaziri ND. Understanding Iron: Promoting Its Safe Use in Patients With Chronic Kidney Failure Treated by Hemodialysis. Am J Kidney Dis. 61(6):992-1000, 2013

156. Moradi H, Vaziri ND, Kashyap ML, Said H, Kalntarzadeh K. Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword. J. Renal Nutrition, 23: 203-206, 2013

157. Nicholas SB, MD, Vaziri ND,. Norris KC. What Should Be The Blood Pressure Target For Patients With Chronic Kidney Disease? Current Opinion in Cardiology ) 28(4):439-45, 2013

158. Zhou XJ, Fenves A, Vaziri ND, Saxena R. CHAPTER 28. RENAL CHANGES WITH AGING and END-STAGE RENAL DISEASE. In Heptinstall's Text Book of Pathology of the Kidney, 2014

159. Vaziri ND. Altered Lipid Metabolism and Serum Lipids in Kidney Disease and Kidney Failure in text book of Nutritional Management of Renal Disease Third Edition (Massry S, Kalantar-Zadeh K, Kopple J editors) Academic Press (publisher).

160. Fishbane S, Matthew A, Vaziri ND. Iron Toxicity: Relevance for Dialysis Patients. Nephrol Dial Transplant 29(2):255-9, 2014

161. Vaziri N D. Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease. Clin Exp Nephrol 18(2):265-8, 2014

162. Pahl MV, Vaziri ND. Immune Function in CKD in text book of Chronic Kidney Disease (Paul L. Kimmel and Mark E. Rosenberg, Editors) Elsevier Inc (Publisher), Chapter 24- pages 285-297, 2014

163. Vaziri ND. Toxic effects of indiscriminate use of intravenous iron preparations in chronic kidney disease. Nephrol News Issues 28(2):4-5, 2014

164. Robles L, Vaziri ND, Ichii H. Role of Oxidative Stress in the Pathogenesis of Pancreatitis: Effect of Antioxidant Therapy. Pancreatic Disorders & Therapy http://dx.doi.org/10.4172/2165-7092.10001123:1, 2013,

165. Jankowski J, Westhof T, Vaziri ND, Ingrosso D, Perna AF.GASSES AS UREMIC TOXINS: IS THERE SOMETHING IN THE AIR ? Seminars in Nephrology. 34 (2)135–150, 2014

166. Williams S, Vaziri ND, Nicholas SB, Norris KC. ACEIs as Antihypertensives in African Americans - A 21st Century Perspective. ACE Inhibitors in Medicine, uses, mechanisms of action and potential adverse effects. edited: Onuigbo M. Nova Science Publishers, Inc.

167. Moradi H, Streja E, Vaziri ND, Kalantar-Zadeh K. Elevated HDL Cholesterol and Cardiovascular Mortality in maintenance hemodialysis patients Nephrol Dial Transplant. 29(8):1554-62. 2014

168. Mafra D, Lobo JC , Barros AF, Koppe L, Vaziri ND, Fouque D. Role of altered intestinal microbiota in systemic inflammation and cardiovascular disease in CKD. Future Microbiology 9: 399-410, 2014.

169. Williams SF, Nicholas SB, Vaziri ND, Norris KC. African Americans, Hypertension and the Renin Angiotensin System. World Journal of Cardiology World J Cardiol. 6(9): 878-889. 2014.

170. Vaziri ND. Role of the gut microbial translocation in the pathogenesis of systemic inflammation in patients with End-stage renal disease. Digestive diseases & Science 59(9):2020-2, 2014

171. Vaziri ND, Moradi H. Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome. Am J Kidney Dis.;64(4): 495-8. 2014

172. ZhaoYY, Chengd XL, Vaziri ND, Liu S, Lin LC. UPLC-based metabonomics applications for discovering biomarkers of diseases in clinical chemistry. Clinical Biochemistry 47(15):16-26, 2014

173. Safar S, Navab K, Shabihkhani M, Pourtabatabaei N, Tabarestani N, Esmaeili M, Sharifzadeh M, Naghshineh S, Moradi H, Vaziri ND. Role of HDL, ApoA-I, and Related Peptides in Protection Against Atherosclerosis. Curr Topics Peptides & Protein Res 15: 79-89, 2014.

174. Vaziri ND Risk factors: HDL-cholesterol levels and mortality in patients with ESRD. Nat Rev Nephrol. 10(11):621-3. 2014

175. Vaziri ND. Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome- in Dyslipidemias: Pathophysiology, Evaluation and Management (A. Garg editor) Springer Science publisher 2015

176. Zhao YY, Vaziri ND, Lin LC. Lipidomics: new insight into the kidney disease. Advances in Clinical Chemistry 68:153-75, 2015

177. Lau WL; Kalantar-Zadeh K; Vaziri ND. Gut inflammation in chronic kidney disease. Nephron 130:92-98, 2015

178. Pahl MV, ND. Vaziri. The CKD - Colonic Axis. Seminars in Dialysis 28(5):459-63, 2015

179. Vaziri ND. Oxidative Stress and its implications in CKD, in Oxford Text Book of Nephrology, Fourth Edition (Turner N, Goldsmith D, Winearls C, Lameire N, Himmelfarb J, Remuzzi G, Editors) Oxford University press Inc (publisher), 2016

180. Vaziri ND. Kalantar-Zadeh K; Wish JB. New Options for Iron Supplementation in Maintenance Hemodialysis Patients. Am J Kidney Dis 67(3):367-75, 2016

181. Vaziri ND, Zhao YY, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. Nephrol Dial Transplant.;31(5):737-46, 2016

182. Vaziri ND. HDL abnormalities in nephrotic syndrome and chronic kidney disease. Nature Reviews Nephrol 2016 Jan;12(1):37-47, 2016

183. Vaziri ND, Anzalone DA, Catini J. Statins in Chronic Kidney Disease: When and When Not to Use Them. J Family Practice . Aug;65(8 Suppl). pii: supp_az_0816. PMID: 27660844, 2016

184. Vaziri N. Effect of synbiotic therapy on gut-derived uremic toxins and the intestinal microbiome in patients with CKD. Clin J Am Soc Nephrol. 11(2):199-201, 2016

185. Vaziri ND. Safety Issues in Iron Treatment in CKD. Semin Nephrol. 36(2):112-118, 2016

186. Vaziri ND. Disorders of lipid metabolism in Nephrotic Syndrome: mechanisms and consequences. Kidney Int 90(1):41-52, 2016

187. Rostoker G, Vaziri N, Fishbane S: Iatrogenic iron overload in dialysis patients at the beginning of the 21 st century. Drugs 76(7):741-57, 2016

188. Macdougall IC et al. Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. Kidney Int. 89(1):28-39, 2016

189. Lau WL, Vaziri ND. Urea, a true uremic toxin: The Empire Strikes Back. Clin Science. 131(Issue 1): 3-12, 2016.

190. Solak Y, Afsar B, Vaziri ND, Aslan G, Yalcin CE, Covic A, Kanbay M. Hypertension as an autoimmune and inflammatory disease. Hypertens Res. 2016 Apr 7. doi: 10.1038/hr. 2016.35. PMID: 27053010.

191. Moradi H, Vaziri ND. Effect of resveratrol on progression of polycystic kidney disease: a case of cautious optimism. Nephrol Dial Transplant 2016. pii: gfw097. [Epub ahead of print]. PMID: 27190353

192. Lau WL, Vaziri ND. The leaky gut and altered microbiome in chronic kidney disease. J Renal Nutrition (Inpress)

193. Afsar B, Vaziri ND. Aslan G. Kanbay M. Gut Hormones and Gut Microbiata: Implications for Kidney Function and Hypertension. J Am Soc Hypertens. 2016 Nov 1. pii: S1933-1711(16)30551-4.

ORIGINAL PUBLICATIONS

1. Rosen, S.M., Mirahmadi, K., Vaziri, N.D.: Relationship of vascular reactivity and plasma renin concentration in patients with terminal renal failure. Proceedings of Kidney Foundation Clinical Dialysis and Transplantation 4:45-47, 1975.

2. Davidson, M., Fisher, M., Vaziri, N.D., and Schaffer, M.: Effect of protein intake and dialysis on the abnormal growth hormone, glucose, and insulin homeostasis in uremia. Metabolism 25(4):455-464, 1976.

3. Mirahmadi, K., Imparato, B., Vaziri, N.D., and Rosen, S.M.: Histidine supplementation in treatment of anemia in dialysis patients. Dialysis and Transplantation 5(2):15-19, 1976.

4. Vaziri, N.D., Barnes, J., Mirahmadi, K., Ehrlich, R., and Rosen, S.M.: Compression neuropathy subsequent to renal transplantation. Urology 7:145-147, 1976.

5. Kaplan, M., Mirahmadi, K., Winder, R., Goraman, J., Vaziri, N.D., and Rosen, S.: Comparison of "PTFE" and bovine grafts for blood access in dialysis patients. Proc. ASAIO 22:388-393, 1976.

6. Giberson, A., Vaziri, N.D., Mirahmadi, K., and Rosen, S.M.: Hemodialysis of acute arsenic intoxication with transient renal failure. Arch. Intern. Med. 136:1303-1304, 1976.

7. Vaziri, N.D., Goldman, R., Schultze, R., Lee, D.B., and Rosen, S.: Maintenance hemodialysis in myeloma kidney. Western J. of Medicine 126:91-94, 1977.

8. Vaziri, N.D., Kumar, K., Mirahmadi, K., and Rosen, S.M.: Hemodialysis in treatment of actue chloral hydrate poisoning. Southern Medical Journal 70:377-378, 1977.

9. Lee, D.B.N., Ehrlich, R.M., Vaziri, N.D., Sambhi, M.P., Doud, R.B., Barajas, L., and Schultze, R.G.: Post-transplant hypertension. Urology 9:425-428, 1977.

10. Mirahmadi, K.S., Paul, W.L., Winer, R.L., Byer, B., Gorman, J.T., Vaziri, N.D., and Rosen, S.M.: Serum ferritin levels as a determinant of iron requirement in hemodialysis patients. JAMA 238(7):601-604, 1977.

11. Barton, C.H., and Vaziri, N.D.: Listeria septicemia associated with maintenance hemodialysis. Dialysis and Transplantation 24-25, 1977.

12. Vaziri, N.D., Barton, C., Ness, R., and Mirahmadi, K.: Special uses of cimetidine. Ann. Intern. Med. 88(2):266-267, 1978.

13. Vaziri, N.D., Barton, C., Ness, R., and Clark, D.: Dialysability of theophylline. Journal of Dialysis 2(3):243-249, 1978.

14. Vaziri, N.D., Ness, R., and Barton, C.: Hemodialysis clearance of cimetidine. Arch. Intern. Med. 138:1685-1686, 1978.

15. Vaziri, N.D., Robinson, M.A., Barton, C., and Ness, R.: Control of bleeding from cannulation sites with topical thrombin in dialyzed patients. Journal of Dialysis 2(4):393-398, 1978.

16. Vaziri, N.D.: Rapid hemostasis with topical thrombin after hemodialysis. Ann. Intern. Med. 89(6):936-937, 1978.

17. Barton, C., Vaziri, N.D., Ness, R., and Mirahmadi, K.: Cimetidine in the management of metabolic alkalosis induced by nasogastric drainage. Arch Surg. 114:70-74, 1979.

18. Vaziri, N.D., Ness, R.L., Fairshter, R.D., Smith, W.R., and Rosen, S.M.: Nephrotoxicity of paraquat in man. Arch. Intern. Med. 139:172-174. 1979.

19. Barton, C.H., and Vaziri, N.D.: Central retinal vein occlusion associated with hemodialysis. Amer. J. Med. Sci. 227:39-47, 1979.

20. Afrasiabi, M.A., Vaziri, N.D., Gwinup, G., Mays, M., Barton, C.H., Ness, R., and Valenta, L.J.: Thyroid function studies in the nephrotic syndrome. Ann. Intern. Med. 90:335-338, 1979.

21. Vaziri, N.D., Nellans, R.E., Brueggemann, R.M., Barton, C.H., and Martin, D.C.: Renal tubular dysfunction in transplant kidneys. Southern Medical Journal 72(5):530-536, 1979.

22. Vaziri, N.D., Jemison-Smith, P., and Wilson, A.F.: Hemorrhagic pneumonitis subsequent to intravenous injection of charcoal ligher fluid. Ann. Intern. Med. 90(5):794-795, 1979.

23. Vaziri, N.D., and Warner, A.S.: Peritoneal dialysis clearance of endogenous lactate. Journal of Dialysis 3(1):107-113, 1979.

24. Vaziri, N.D., Ness, R., and Barton, C.H.: Peritoneal dialysis clearance of cimetidine. Amer. J. Gastroenterology 71(6):572-576, 1979.

25. Mirahmadi, K.S., Vaziri, N.D., Winder, R.L., Giberson, A., Gentile, G.E., Miller, R.B., and Gorman, J.T.: Hemodialysis treatment and transplantation in patients with hypernephroma. Southern Med. J. 72(8):959-964, 1979.

26. Cesario, T.C., Vaziri, N.D., Slater, L., and Tilles, J.G.: A study of the inactivators of fibroblast interferon found in human serum. Journal of Infection and Immunity 24(3):851-855, 1979.

27. Fairshter, R.D., Vaziri, N.D., Smith, W.R., Glauser, F.L., and Wilson, A.F.: Paraquat poisoning: An analytic toxicologic study of three cases. J. Toxicology 12:259-266, 1979.

28. Vaziri, N.D., Ness, R., Wellikson, L. Barton, C.H., and Greep, N.: Bicarbonate-Buffered Peritoneal Dialysis - An Effective Adjunct in the Treatment of Lacticacidosis. Amer. J. Med. 67(3):392-396, 1979.

29. Fairshter, R.D., Vaziri, N.D., Wilson, A.F., and Fugl-Meyer, A.R.: Respiratory physiology before and after hemodialysis in chronic renal failure patients. Amer. J. Med. Sci. 278(No. L):11-18, 1979.

30. Vaziri, N.D.: Topical thrombin and control of bleeding from the fistula puncture sites in dialyzed patients. Nephron. 24:254-256, 1979.

31. Mirahmadi, M.D., Vaziri, N.D., and Gorman, J.T.: Controlled evaluation of hemodialysis patients on nandrolone decanoate (ND) testosterone enanthate (TE). Proceedings ASAIO Vol. XXV:449-454, 1979.

32. Miller, A., and Vaziri, N.D.: Recurrent atraumatic splinter hemorrhages in otherwise healthy individuals. Southern Med. J. 72:1418-1420, 1979.

33. Vaziri, N.D., and Prakash, R.: Echocardiographic evaluation of cardiac size and function and effect of hemodialysis in patients with end-stage renal disease. Amer. J. Med. Sci. 278:201-205, 1979.

34. Vaziri, N.D., Miyada, D., Saiki, J., and Robinson, M.A.: Reassessent of fistula puncture site blood loss. Journal of Dialysis 3(4):361-366, 1979.

35. Vaziri, N.D., and Lester, K.: Use of microanalytic laboratory methods to reduce blood loss in dialysis patients. Journal of Dialysis 3(4):367-374, 1979.

36. Novey, H.S., Wells, I.D., and Vaziri, N.D.: Prevalence of aspergillus and candida precipitins in renal dialysis and transplant patients. Journal of Dialysis 3(4):349-360, 1979.

37. Vaziri, N.D., Saiki, J.K., and Hughes, W.: Clearance of lidocaine by hemodialysis. Southern Med. J. 72:1567-1568, 1979.

38. Barton, C.H., Vaziri, N.D., and Spears, G.: Nephrotic syndrome associated with adenocarcinoma of the breast. Amer. J. Medicine 68:308-312, 1980.

39. Vaziri, N.D., and Forthal, D.: Hypoalbuminemia after renal transplantation. Archives of Surgery 155:286-289, 1980.

40. Vaziri, N.D., Saiki, J., Barton, C.H., and Ness, R.L.: Hemodialyzability of acetazolamide. Southern Med. J. 73:422-423, 1980.

41. Barton, C., Sterling, L., and Vaziri, N.D.: Rhabdomyolysis and acute renal failure associated with phencyclidine intoxication. Arch. Intern. Med. 140:568-569, 1980.

42. Vaziri, N.D., Smith, P.J., and Wilson, A.F.: Toxicity with intravenous injectin of naphtha in man. Clinical Toxicology 16(3):335-343. 1980.

43. Barton, C., Vaziri, N.D., Seltzer, J., Lester, K., and Morton, M.: Tense ascites, a reversible component of transplant renal failure associated with cirrhosis. Dialysis & Transplantation 6:602-604, 1980.

44. Flores, O.R., Sun, L., Vaziri, N.D., and Miyada, D.: Colorimetic rate method for the determination of creatinine as implemented by the Beckman creatinine analyzer 2. Amer. J. Med. Technol. 46(11):792-798, 1980.

45. Vaziri, N.D., Cesario, T., Valentic, J., Saiki, J., and Tilles, J.: Hemodialysis of erythromycin. Drug Intel. & Clin. Pharm. 14:549-551, 1980.

46. Bretza, J., Novey, H., Vaziri, N.D., and Warner, A.: Hypertension, a complication of danazol therapy. Arch. Intern. Med. 140:1379-1380, 1980.

47. Morrison, J.T., Wilson, A.F., Vaziri, N.D., and Brunsting, L.: Determination of pulmonary tissue volume, pulmonary capillary blood flow, and diffusing capacity of the lung before and after hemodialysis. Int. J. Artif. Organs 3(5):259-262, 1980.

48. Mirahmadi, M., and Vaziri, N.D.: Cystic transformation of end-stage kidneys in patients undergoing hemodialysis. Int. J. Artif. Organs 3(5):267-270, 1980.

49. Vaziri, N.D., Risk, C., Martin, D.C., and Novey, H.S.: Comparison of hyperlipidemia in dialysis patients, renal transplant recipients, and steroid treated nonrenal patients. J. of Dialysis 4(2&3):63-71, 1980.

50. Vaziri, N.D., and Upham, T.: Hemodialysis of clearance of arsenic. Clinical Toxicology 17(3):451-456, 1980.

51. Vaziri, N.D., Branson, H., and Ness, R.: Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome. Amer. J. Med. Sci. 280(3):167-171, 1980.

52. Vaziri, N.D., Showsky, R., and Saiki, J.: Antidiuretic hormone in end-stage renal disease. J. of Dialysis 4:73-81, 1980.

53. Mirahmadi, M.K., and Vaziri, N.D.: Long-term nandrolone and testosterone administration in hemodialysis patients. A comparison of the hematopoietic, anabolic, and endocrine effects. Drug Intell. and Clin. Pharm. 14:493-497, 1980.

54. Vaziri, N.D., Byrne, C., Ryan, G., and Wilson, A.F.: Preservation of post prandial alkaline tide despite inhibition of gastric acid secretion. Amer. J. Gastroenterology 74(4):328-331, 1980.

55. Vaziri, N.D., Skowsky, R., and Warner, A.: Effect of isoosmolar volume reduction during hemofiltration on plasma antidiuretic hormone in patients with crhonic renal failure. Int. J. Artif. Organs 3(6):322-325, 1980.

56. Vaziri, N.D., Skowsky, R., Saiki, J., and Warner, A.: Hemodialysis studies of antidiuretic hormone. J. of Dialysis 4(4):185-190, 1980.

57. Saiki, J.K., Vaziri, N.D., Naeim, F., and Meshkinpour, H.: Dialysis-induced changes in muscle strength. J. of Dialysis 4(4):191-201, 1980.

58. Barton, C.H., Sterling, M.L.., Thomas, R., Vaziri, N.D., Byrne, C., and Ryan, G.: Ineffectiveness of intravenous ascorbic acid as an acidifying agent in man. Arch. Intern. Med. 141:211-212, 1981.

59. Vaziri, N.D., Pratt, H., Saiki, J., and Starr, A.: Evaluation of somatosensory pathway by short latency evoked potentials in end-stage renal disease maintained on hemodialysis. Int. J. Artif. Organs 4(1):17-22, 1981.

60. Vaziri, N.D., Thomas, R., Sterling, M., Seiff, K., Pahl, M.V., Davila, J., and Wilson, A.: Toxicity with intravenous injection of crude marijuana extract. Clinical Toxicology 18(3):353-366, 1981.

61. Vaziri, N.D., Gwinup, G., Martin, D., and Seltzer, J.: Thyroid function in chronic renal failure after successful renal transplantation. Clinical Nephrology 15(3)131-134, 1981.

62. Meshkinpour, H., and Vaziri, N.D.: Acute rhabdomyolysis associated with adenovirus infection. J. of Infectious Diseases 143(1):133-134, 1981.

63. Vaziri, N.D., Stokes, J., and Treadwell, T.R.: Lactic acidosis: A complication of papaverine overdose. Clinical Toxicology 18(4):417-423, 1981.

64. Powers, D., Vaziri, N.D., Muhalwas, K., Hubell, F.A., Weber, M., and Mirahmadi, K.: Ticrynafen-induced acute renal failure. Clinical Toxicology 18(4):425-430, 1981.

65. Mirahmadi, M.D., and Vaziri, N.D.: Hearing loss in end-stage renal disease: Effect of dialysis. J. of Dialysis 4(4):159-165, 1981.

66. Barton, C.H., Sterling, M.L., and Vaziri, N.D.: Phencyclidine intoxication: Clinical experience in 27 cases confirmed by urine assay. Ann. Emerg. Med. 10(5):243-246, 1981.

67. Vaziri, N.D., Barton, C.H., Ravikumar, G.R., Martin, D.C., Ness, R.L., and Saiki, J.K.: Femoral neuropathy: A complication of renal transplantation. Nephron 28:30-31, 1981.

68. Nikakhtar, B., Vaziri, N.D., Khonsari, F., Gordon, S., and Mirahmadi, M.K.: Urolithiasis in patients with spinal cord injury. Paraplegia 19:363-366, 1981.

69. Zetin, M., Plon, L., Vaziri, N.D., Cramer, M., and Creco, D.: Lithium carbonate dose and serum level relationships in chronic hemodialysis patients. Amer. J. of Psychiatry 138:1387-1388, 1981.

70. Vaziri, N.D., Craddock, C.G., Hays, E.F., Schultze, R.G., and Rodensky, D.: Corticosteroids and granulopoiesis: Effects upon in vitro colony formation. Amer. J. Med. Sci. 282(3):104-115, 1981.

71. Vaziri, N.D., Bruno, A., Byrne, C., Mirahmadi, M.K., Nikakhtar, B., Gordon, S., and Zeien, L.: Maintenance hemodialysis in chronic renal failure associated with spinal cord injury. Artificial Organs 6(1):13-16, 1981.

72. Vaziri, N.D., Nikakhtar, B., Gordon, S.: Hyperoxaluria in chronic renal disease associated with spinal cord injury. Paraplegia 20:48-53, 1982.

73. Mirahmadi, M., Vaziri, N.D., Ghobadi, M., Nikakhtar, B., and Gordon, S.: Survival on maintenance dialysis in patients with chronic renal failure associated with paraplegia and quadriplegia. Paraplegia 20:43-47, 1982.

74. Vaziri, N.D., Byrne, C., Mirahmadi, K., Golji, H., Nikakhtar, B., Alday, B., and Gordon, S.: Hematologic features of chronic renal failure associated with spinal cord injury. Articifical Organs 6(1):69-72, 1982.

75. Vaziri, N.D., Nikakhtar, B., and Gordon, S.: Lipid abnormalities in chronic renal failure associated with spinal cord injury. Paraplegia 20:183-189, 1982.

76. Elias, A.N., Pahl, M., Stone, S., Vaziri, N.D., and Valenta, L.: Modulatory role of gamma-aminobutyric acid (GABA) in the regulation of gonadotropin secretion in patients with chronic renal failure. Int. J. Artif. Organs 5(1):13-16, 1982.

77. Branson, H., Vaziri, N.D., and Slater, L.: Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiency. J.N.M.A. 74(4):339-343, 1982.

78. Fairshter, R.D., Vaziri, N.D., and Mirahmadi, M.K.: Lung pathology in chronic hemodialysis patients. Int. J. Artif. Organs 5:97-100, 1982.

79. Vaziri, N.D., Cesario, T., Mootoo, K., Zeien, L., Gordon, S., and Byrne, C.: Bacterial infections in patients with chronic renal failure: Occurrence with spinal cord injury. Arch. Intern. Med. 142:1273-1276, 1982.

80. Barton, C.H., Mirahmadi, M.K., and Vaziri, N.D.: The effects of long-term testosterone administration on pituitary-testicular axis in end-stage renal failure. Nephron 31:61-64, 1982.

81. Meshkinpour, H., and Vaziri, N.D.: Association of myoglobinuria with adenovirus infection. West. J. Med. 137:130-132. 1982.

82. Meshkinpour, H., Vaziri, N.D., and Gordon, S.: Gastrointestinal pathology in end-stage renal disease associated with spinal cord injury. Amer. J. Gastroenterology 77(8):562-565, 1982.

83. Vaziri, N.D., Ngo, J.T., Ibsen, K.H., Muhalwas, K., and Roy, S.: Deficiency and urinary losses of factor XII in adult nephrotic syndrome. Nephron 32:342-346, 1982.

84. Fairshter, R.D., and Vaziri, N.D.: Pulmonary pathology in patients with chronic renal failure associated with spinal cord injury. Respiration 44:58-62, 1983.

85. Ibsen, K.H., Ngo, J.L.T., Sanders, D.A., Vaziri, N.D., and Hung, E.K.: Use of the gradient plate immunodiffusion technique. J. Immunological Methods 56:381-387, 1983.

86. Vaziri, N.D., Hollander, D., Hung, E., Vo, M., and Dadufalza, L.: Impaired intestinal absorption of vitamin D-3 in azotemic rats. Amer. J. Clin. Nutrition 37:403-406, 1983.

87. Mirahmadi, M.K., Barton, C., Vaziri, N.D., Gordon, S., and Penera, N.: Nutritional evaluation of hemodialysis patients with and without spinal cord injury. J. Amer. Paraplegia Soc. 6(2):36-40, 1983.

88. Mirahmadi, M.K., Byrne, C., Barton, C., Penera, N., Gordon, S., and Vaziri, N.D.: Prediction of creatinine clearance from serum creatinine in spinal cord injury patients. Paraplegia 21:23-29, 1983.

89. Vaziri, N.D., Mirahmadi, M.K., Barton, C.H., Eltorai, I., Gordon, Byrne, C., Pahl, M.V.: Clinicopathological characteristics of dialysis patients with spinal cord injury. J. Amer. Paraplegia Soc. 6(1):3-6, 1983.

90. Feistel, C., Vaziri, N.D., Darwish, R.: Evaluation of in-line sensors for continuous measurement of potassium concentration. Proceedings Intl. Federation of Clin. Chemistry, Oslo, Norway, 239-250, 1983.

91. Sharma, B., Vaziri, N.D., Valenta, L., and Tilles, J.: Immuno-suppressive and immunizing activities in human tumor cell-free extract. Oncology 40:351-356, 1983.

92. Vaziri, N.D., Wellikson, L., Gwinup, G., and Byrne, C.: Lipid fractions in primary hyperparathyroidism before and after surgical cure. ACTA Endocrinol. 102:539-542, 1983.

93. Pahl, M.V., Vaziri, N.D., Gordon, S., and Tuero, S.: Cardiovascular pathology in dialysis patients with spinal cord injury. Artificial Organs 7(4):416-419, 1983.

94. Pahl, M.V., and Vaziri, N.D.: In-vivo and in-vitro hemodialysis studies of thiocyanate. Clinical Toxicology 19(9):965-974, 1983.

95. Chan, N., Barton, C.H., Mirahmadi, M.K., Gordon, S., and Vaziri, N.D.: Erythropoiesis associated with viral hepatitis in end-stage renal disease. Amer. J. Med. Sci. 287:56-58, 1984.

96. Vaziri, N.D.: Long-term hemodialysis in spinal cord injured patients. Paraplegia 22:110-114, 1984.

97. Gutman, S., and Vaziri, N.D.: Effect of hemodialysis on intraocular pressure. Artifical Organs 8(1):62-65, 1984.

98. Vaziri, N.D., Barton, C.H., Warner, A., Toohey, J., Litner, C., Mullin, P., Samiminia, B., O'Donnell, M., Mallot, K.: Comparison of four dialyzer-dialysate combinations: Effects on blood gases, cell counts, complement, contact factors and fibrinolytic system. Contributions to Nephrology 37:111-119, 1984.

99. Barton, C., Vaziri, N.D., Gordon, S., Tilles, J.: Renal pathology in end-stage renal disease associated with paraplegia. Paraplegia 22:31-41, 1984.

100. Barton, C., Vaziri, N.D., Gordon, S.: Endocrine pathology in spinal cord injured patients on maintenance dialysis. Paraplegia 22:7-16, 1984.

101. Darwish, R., Elias, A., Vaziri, N.D., Pahl, M.V., Powers, D., Stokes, J.D.: Plasma and urinary catecholamines and their metabolites in chronic renal failure. Arch. Intern. Med. 144:69-71, 1984.

102. Vaziri, N.D., Darwish, R., Martin, D.C., Hostetler, J.: Acquired renal cystic disease in renal transplant recipients. Nephron 37:203-205, 1984.

103. Darwish, R., Vaziri, N.D., Gupta, S., Novey, H., Spear, G., Licorish, K., Powers, D., Cesario, T.: Focal renal cortical necrosis associated with Zomepirac. Amer. J. Med. 76:1113-1117, 1984.

104. Vaziri, N.D., Maksy, M., Lewis, M., Martin, D., Edwards, K.: Massive mediastinal hematoma caused by a double-lumen subclavian catheter. Artifical Organs 8(2):223-226, 1984.

105. Fairshter, R.D., Vaziri, N.D., Dearden, L., Malott, K., Cesario, M.: Effect of dimethylthiourea on paraquat toxicity in rats. Toxicology and Applied Pharmacology 74:150-154, 1984.

106. Vaziri, N.D., Hollander, D., Kennedy, K., Palmer, K.L., Dadufalza, V.L.: Intestinal absorption of vitamin A in experimental uremia. ACTA Vitaminol. Enzymol. 6(1):41-45, 1984.

107. Vaziri, N.D., Toohey, J.A., Paule, P., Hung, E., Darwish, R., Barton, C.H., Alikhani, S.: Urinary excretion and deficiency of prothrombin in nephrotic syndrome. Amer. J. Med. 77(3):433-436, 1984.

108. Vaziri, N.D., Toohey, J., Paule, P., Alikhani, S., Hung, E.: Effect of hemodialysis on contact group of coagulation factors, platelets and leukocytes. Amer. J. Med. 77:437-441, 1984.

109. Barton, C.H., Pahl, M.V., Vaziri, N.D., Cesario, T.: Renal magnesium wasting associated with amphotericin B therapy. Amer. J. Med. 77:471-474, 1984.

110. Vaziri, N.D.: Hematopoietic system in paraplegic patients with end-stage renal disease. J. Amer. Paraplegia Soc. 7(3):47-49, 1984.

111. Vaziri, N.D., Paule, P., Toohey, J., Hung, E., Alikhani, S., Darwish, R., Pahl, M.V.: Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch. Intern. Med. 144:1802-1803, 1984.

112. Sharma, B., Vaziri, N.D.: Augmentation of human natural killer cell activity by cyclophosphamide in vitro. Cancer Research 44:3258-3261, 1984.

113. Pahl, M.V., Vaziri, N.D., Ness, R., Barton, C.H.: Central retinal vein thrombosis in hemodialysis patients. Int. J. Artif. Organs 7(5):275-276, 1984.

114. Vaziri, N.D., Wilson, A., Mukai, D., Darwish, R., Rutz, A.L., Hyatt, J.: Dialysis hypoxemia: Role of dialyzer membrane and dialysate delivery system. Amer. J. Med. 77:828-833, 1984.

115. Elias, A., Vaziri, N.D., Farooqui, S., Martin, D.C., Mirahmadi, M.K.: Pathology of endocrine organs in chronic renal failure: An autopsy analysis of 66 patients. Int. J. Artif. Organs 7(5):251-256, 1984.

116. Vaziri, N.D., Bruno, A., Mirahmadi, M.K., Golji, J., Gordon, S., and Byrne, C.: Features of residual renal function in end-stage renal failure associated with spinal cord injury. Int. J. Artif. Organs 7(6):319-322, 1984.

117. Vaziri, N.D., Lopez, G., Nikakhtar, B., Gordon, S., Penera, N.: Peritoneal dialysis in renal failure associated with spinal cord injury. J. Amer. Paraplegia Soc. 7(4):63-65, 1984.

118. Pahl, M., Vaziri, N.D., Saiki, J., Upham, T., Ness, R.: Chronic hemodialysis in end-stage lupus nephritis: Changes in clinical and serological activities. Artif. Organs 8(4):423-428, 1984.

119. Fairshter, R.D., Vaziri, N.D., Farooqui, S., Martin, D.C.: Pulmonary pathology in renal transplant recipients. Int. J. Artif. Organs 7(6):327-330, 1984.

120. Vaziri, N.D., Toohey, J.L., Paule, P., Alikhani, S., Hung, E.: Coagulation abnormalities in patients with end-stage renal disease treated with hemodialysis. Int. J. Artif. Organs 7(6)323-326, 1984.

121. Pahl, M.V., Vaziri, N.D., Ness, R., Nathan, R., Maksy, M.: Association of beta hydroxybutyric acidosis with isoniazide intoxication. Clinical Toxicology 22(2):167-176, 1984.

122. Said, H., Vaziri, N.D., Kariger, R.K., Hollander, D.: Intestinal absorption of 5-methyltetrahydrofolate in experimental uremia. ACTA Vitaminol. Enzymol. 6(4):339-346, 1984.

123. Vaziri, N.D., Byrne, C., Barton, C., Robertson, D., Jay, K., and McDonald, L.: Prevention of metabolic alkalosis induced by gastric fluid loss using H2 receptor antagonist. Gen. Pharmacology 16(2):141-144, 1985.

124. Elias, A.N., Vaziri, N.D., Deftos, L.J., Shinto, R., Valenta, L.J.: Effect of bromocriptine on serum PTH, calcium and phosphate levels in azotemic rats. Gen. Pharmacology 16(1):75-77, 1985.

125. Vaziri, N.D., Winer, L.R., Alikhani, S., Danviriyasup, K., Toohey, J., Hung, E., Gordon, S., Eltorai, I., Paule, P.: Antithrombin deficiency in end-stage renal disease associated with paraplegia: Effect of hemodialysis. Arch. Phys. Med. Rehabil. 66:307-309, 1985.

126. Vaziri, N.D., Winer, R., Toohey, J., Danviriyasup, K., Alikhani, S., Eltorai, I., Gordon, S., Paule, P.: Intrinsic coagulation pathway in end-stage renal disease associated with spinal cord injury treated with hemodialysis. Artificial Organs 9(2):155-159, 1985.

127. Elias, A.N., Vaziri, N.D., Maksy, M.: Plasma norepinephrine, epinephrine and dopamine levels in end-stage renal disease: Effect of hemodialysis. Arch. Intern. Med. 145:1013-1015, 1985.

128. Vaziri, N.D., Barbari, A., Licorish, K., Cesario, T., Gupta, S.: Spectrum of renal abnormalities in acquired immune deficiency syndrome. J.N.M.A. 77(5):369-375, 1985.

129. Akbarpour, F., Afrasiabi, A., Vaziri, N.D.: Severe hyperkalemia caused by indomethacin and potassium supplementation. South. Med. J. 78(6):756-757, 1985.

130. Vaziri, N.D., Said, H., Hollander, D., Barbari, A., Patel, N., Dang, D., Kariger, R.: Impaired intestinal absorption of riboflavin in experimental uremia. Nephron 41:26-29, 1985.

131. Vaziri, N.D., Byrne, C.: Effects of glucose feeding on renal electrolyte and H+ transport. General Pharmacology 16(4):395-398, 1985.

132. Vaziri, N.D., Dure-Smith, B., Miller, R., Mirahmadi, M.K.: Pathology of gastrointestinal tract in chronic hemodialysis patients: An autopsy study of 78 cases. Amer. J. Gastroenterology 80(8):608-611, 1985.

133. Chandy, K.G., Pahl, M.V., Vaziri, N.D., Gupta, S.: Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease. J. Clin. Lab. Immunol. 17:119-124, 1985.

134. Barton, C.H., Vaziri, N.D., DeRaad, C., and Martin, D.C.: Association of ureteropelvic pseudo-obstruction with cryptorchidism. J.N.M.A. 77(12):1010-1013, 1985.

135. Key, P.S., Vaziri, N.D., Childester, M.: Effect of H2 histamine receptor blockade and stimulation on urinary acidification. Gen. Pharmacology 16(6):621-623, 1985.

136. Darwish, R.Y., Fairshter, R., Vaziri, N.D., Rooney, R., Schwartz, G.: Hypoventilation in a case of nonfamilial Parkinson's disease. West. J. Med. 143:383-385, 1985.

137. Tennyson, T.E., Brown, W.S., Vaziri, N.D., Jennison, J.: Event-related potential changes during hemodialysis Int. J. Artif. Organs 8(5):269-276, 1985.

138. Barton, C.H., Khonsari, F., Vaziri, N.D., Byrne, C., Gordon, S., Friis, R.: The effect of modified transurethral sphincterotomy on autonomic dysreflexia. J. Urol. 135:83-85, 1986.

139. Vaziri, N.D., Toohey, J., Powers, D., Keegan, M., Gupta, A., Alikhani, S., Mashood, M., Barbari, A.: Activation of intrinsic coagulation pathway in pre-eclampsia. Amer. J. Med. 80:103-107, 1986.

140. Vaziri, N.D., Winer, R., Alikhani, S., Toohey, J., Paule, P., Danviriyasup, K., Gordon, S., Eltorai, I.: Extrinsic and common coagulation pathways in end-stage renal disease associated with spinal cord injury. Paraplegia 24:154-158, 1986.

141. Elias, A., Vaziri, N.D., Maksy, M.: Plasma beta-endorphin and beta-lipotropin in patients with end-stage renal disease: Effect of hemodialysis. Nephron 43:173-176, 1986.

142. Pahl, M.V., Vaziri, N.D., Martin, D.C.: Pathology of digestive organs in renal transplant recipients. J.N.M.A. 78(8):721-726, 1986.

143. Pahl, M.V., Vaziri, N.D., Dure-Smith, B., Miller, R., Mirahmadi, M.K.: Hepatobiliary pathology in hemodialysis patients: An autopsy study of 78 patients. Amer. J. Gastroenterology 81(9):783-787, 1986.

144. Allen, G.J., Burnett, K.R., Vaziri, N.D., Friedenberg, R.M.: Intravenous digital substraction angiography (DSA) of hemodialysis access fistulae. J.N.M.A. 78(9):825-830, 1986.

145. Suzuki, M., Waldeck, N., Vaziri, N.D., Ascher, M., Simpkin, H., Worcester, B., Charles, A.: The interrelationships of radioimmuno-assayable urinary albumin, renal function and diabetes. Diabetes Res. Clin. Pract. 2:43-50, 1986.

146. Frye, E.B., Vaziri, N.D., Martin, D.C., Farooqui, S.: Cardiovascular pathology in renal transplant recipients. J.N.M.A. 78(12):1187-1191, 1986.

147. Friis, R., Vaziri, N.D., Akbarpour, F., Afrasiabi, A.: Effect of rapid weight reduction with supplemental fasting on liver tests. J. Clin. Gastroenterology 9(2):204 207, 1987.

148. Yousefi, S., Vaziri, N.D., Carandang, G., Cesario, T.: Evaluation of the in vitro production of interferon gamma and other lymphokines in uremic patients. Proc. Soc. Exp. Biol. Med. 184:179 185, 1987.

149. Li, J., Yousefi, S., Sterling, M., Carandang, G., Vaziri, N.D., Pahl, M.V., Cesario, T.: The effect of corticosteroids and other anti-neoplastic agents on the generation of leukocyte migration inhibition factor. J. Clin. Lab. Immunol. 22:13 17, 1987.

150. Vaziri, N.D., Dure Smith, B., Miller, R., Mirahmadi, M.K.: Pancreatic pathology in chronic dialysis patients: An autopsy study of 78 cases. Nephron 46:347 349, 1987.

151. Vaziri, N.D., Byrne, C., Staten, M., Charles, A.: Effect of human insulin administration on urinary acidification in patients with insulin dependent diabetes. Gen. Pharmacology 18(4):441 443, 1987.

152. Elias, A., Vaziri, N.D., Pandian, M.R., Iyer, K., Ansari A.: Gamma aminobutyric acid and dysregulation of TSH secretion in uremic male rats. Nephron 46:301 304, 1987.

153. Elias, A.N., Vaziri, N.D., Pandian, M.R., Iyer, K., Ansari, M.A.: Dopamine and TSH secretion in uremic male rats. Horm. Res. 27:102 108, 1987.

154. Barton, C.H., Vaziri, N.D., Martin, D., Choi, S., Alikhani, S.: Hypomagnesemia and renal magnesium wasting in renal transplant recipients receiving cyclosporine. Amer. J. Med. 83:693-699, 1987.

155. Vaziri, N.D., Winer, R.L., Patel, B., Alikhani, S., Eltorai, I., Gordon, S., Danvirysasup, K., Gonzales, E.C.: Protein C abnormalities in spinal cord injured patients with end stage renal disease. Arch. Phys. Med. Rehabil. 68:791-793, 1987.

156. Vaziri, N.D., Yousefi, S., Chui, J., Li, J., Carandang, G., Stephenson, J., Cesario, T.: Reversal of the effects of cyclosporin A on the production of human interferon gamma. J. Interferon Res. 7:389-395, 1987.

157. Yousefi, S., Chiu, J., Carandang, G., Archibeque, E.G., Vaziri, N.D., Cesario T.: Effect of acetyl salicylic acid on production and action of leukocyte-derived interferons. Antimicrobial Agents and Chemotherapy 31(1):114-116, 1987.

158. Vaziri, N.D., Alikhani, S., Patel, B., Nguyen, Q., Barton, C., Gonzales, E.C.: Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron 49:20-23, 1988.

159. Williams, J.H., Fairshter, R.D., Ulich, T.R., Crosby, S., Chen, M., Rosario, L., Vaziri, N.D.: Adverse effects of (15S)-15-Methyl-prostaglandin E1 in normal and paraquat-exposed rats. Toxicology and Applied Pharmacology 92:330-334, 1988.

160. Vaziri, N.D., Chang, D., Malekpour, A., Radaht, S.: Pancreatic enzymes in patients with end-stage renal disease maintained on hemodialysis. Amer. J. Gastroenterology 83(4):410-412, 1988.

161. Elias, A.N., Vaziri, N.D., Pandian, M.R., Iyer, K., Ansari, M.A.: Endogenous opioids and TSH secretion in azotemic male rats. Neuroendocrinology 47:181-185, 1988.

162. Elias, A.N., Vaziri, N.D., Pandian, M.R., Powers, D., Domurat, E.: Atrial natriuretic peptide and arginine vasopressin in pregnancy and pregnancy induced hypertension. Nephron 49:140-143, 1988.

163. Vaziri, N.D., Pham, Q.G.H., Akbarpour, F., Afrasiabi, A., Paule, P., Alikhani, S., Toohey, J.: Blood coagulation system in obesity. J. Obesity and Weight Regulation 7(1):17-21, 1988.

164. Pahl, M.V., Vaziri, N.D., Akbarpour, F., Afrasiabi, A., Friis, R.: Effect of rapid weight loss with supplemented fasting on serum electrolytes, lipids, and blood pressure. JNMA 80(7):803-809, 1988.

165. Fairshter, R.D., Vaziri, N.D., Crosby, S.A., Rosario, L., Toohey, J.A., Ulich, T.R.: Effect of dimethylthiourea on plasma paraquat concentration. Toxicology 50:47-56, 1988.

166. Pahl, M.V., Vaziri, N.D., Leitman, P.S., Nguyen, T.: Effect of renal mass reduction on kidney tissue concentration of gentamycin following a single dose. Res. Comm. in Chem. Pathol. and Pharmacol. 60(3):405-408, 1988.

167. Elias, A.N., Vaziri, N.D., Pandian, M.R., Domurat, E., Ansari, M.A., Yazdani, M.: Atrial natriuretic peptide, arginine vasopressin, and renin-angiotensin system in carbon tetrachloride-induced hepatitis in rats. Res. Comm. in Chem. Pathol. and Pharmacol. 60(3):401-404, 1988.

168. Vaziri, N.D., Hollander, D., Dearden, L., Mallott, K., Martin, R.A., Rosario, L.: Effects of dietary fatty acid saturation on serum and tissue cholesterol concentrations and fecal sterol excretion: A chronic metabolic study in the rat. Res. Comm. in Chem. Pathol. and Pharmacol. 61(2):245-256, 1988.

169. Wink, J., Vaziri, N.D., Barker, S., Hyatt, J., Ritchie, C.: The effect of hemodialysis on whole blood, plasma and erythrocyte viscosity. Int. J. Artif. Organs 11(5):340-342, 1988.

170. Le, N., Yousefi, S., Vaziri, N., Carandang, J., Ocariz, J., Cesario, T.: The effect of beta-estradiol, progesterone and testosterone on the production of human leukocyte derived interferons. J. Biological Regulators and Homeostatic Agents 2(4):199-204, 1988.

171. Elias, A.N., Vaziri, N.D., Pandian, M.R., Iyer, K., Ansari, A., Yazdani M.: Gonadtropin secretion in azotemic male rats: Effect of opioid blockade. Horm. Res. 30:39-43,1988.

172. Cesario, T.C., McCloskey, M., Carandang, G., Yousefi, S., Chiu, J., Vaziri, N.D.: Calcium and the production of interferon by human peripheral blood mononuclear cells. J. Interferon Res. 8:783-792, 1988.

173. Elias, A.N., Vaziri, N.D., Pandian, M.R., Kaupke, C.J.: Plasma concentrations of atrial natriuretic peptide, arginine vasopressin and hormones of the renin-angiotensin system in patients with end-stage renal disease. Int. J. Artif. Organs 12:153-158, 1989.

174. Vaziri, N.D., Barbari, A., Hollander, D., Vincent, T., Tran, L., Oveisi, F., Pahl, M.V., Bissar, L.: Effect of experimental azotemia on intestinal transport of butyric acid. Soc. Exp. Biol. and Med. 190:150-154, 1989.

175. Vaziri, N.D., Shah, G.M., Winer, R.L., Gonzales, E., Patel, B., Alikhani, S., Nguyen, Q.X., Yamamoto, S.: Coagulation cascade, fibrinolytic system, antithrombin III, protein C and protein S in patients maintained on continuous ambulatory peritoneal dialysis. Thrombosis Research 53:173-180, 1989.

176. Nageotte, M., Hurwitz, S.R., Kaupke, J., Vaziri, N.D., Pandian, M.R.: Atriopeptin in the twin transfusion syndrome. Obstet. Gynecology 73:867-870, 1989.

177. Barbari, A., Vaziri, N.D., Benavides, I., Chen, Y.T., Said, H., Pahl, M.V.: Intestinal transport of pyridoxine in experimental renal failure. Life Sciences 45(7):663-669, 1989.

178. Pahl, M.V., Vaziri, N.D., Barbari, A., Saadai, B., Oveisi, F., Seo, M.: Intestinal absorption of L-ascorbic acid in rats with renal failure. Proc. Soc. Exp. Biol. and Med. 191(4):332-336, 1989.

179. Elias, A.N., Vaziri, N.D., Pandian, M.R., Ansari, M.A.: Relationship between B-endorphin/B-lipotropin, hyperglycemia, and hyperinsulinemia in obese male Zucker rats. Proc. Soc. Exp. Biol. and Med. 192:157-160, 1989.

180. Barton, C.H., Vaziri, N.D., Mina-Araghi, S., Crosby, S., Seo, M.I.: Effects of cyclosporine on magnesium metabolism in rats. J. Lab. Clin. Med. 114:232-236, 1989.

181. Vaziri, N.D., Ritchie, C., Brown, P., Kaupke, J., Atkins, K., Barker, S., Hyatt, J.: Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients. ASAIO Transactions 35(3):505-508, 1989.

182. Miyada, D.S., Fagin, A., Pirkle, H., Ocariz, J., Vaziri, N.D.: Lactate dehydrogenase isoenzyme composition of human platelets. Clin. Chem. 35(12):2325-2326, 1989.

183. Yousefi, S., Vu, D., Carandang, G., Yamamoto, R., Granger, G., Vaziri, N.D., Ocariz, J., Cesario, T.: The effect of vitamin D3 on the production of cytotoxic factors by human peripheral blood mononuclear cells. Cancer Research 49:5083-5086, 1989.

184. Elias, A.N., Vaziri, N.D., Domurat, E.S., Pandian, M.R., Ansari, M.A., Yazdani, M.: Atrial natriuretic peptide, arginine vasopressin, aldosterone and plasma renin activity in carbon tetrachloride-induced cirrhosis in rats. J. Pharmacol. Exp. Therap. 252(1):438-441, 1990.

185. Kaupke, C.J., Vaziri, N.D., Sampson, J.R., Atkins, K.: Effect of erythropoietin therapy on diet and dialysis clearances in hemodialysis patients. Int. J. Artif. Organs 13(4):218-222, 1990.

186. Vaziri, N.D., Miyada, D.S., Kim, I., Reid, J., Ocariz, J.: Serum LDH and LDH isoenzymes in chronic renal failure: Effect of hemodialysis. Int. J. Artif. Organs 13(4):223-227, 1990.

187. Pahl, M.V., Vaziri, N.D., Benavides, I., Khamiseh, G., Oveisi, F.: Intestinal absorption of vitamin E in experimental renal failure. Proc. Soc. Exp. Biol. and Med. 193:125-128, 1990.

188. Pahl, M.V., Barbari, A., Vaziri, N.D., Hollander, D., Sanchez, M., Oveisi, F., Patel, N.: Intestinal absorption of arachidonic acid in experimental azotemia. Life Sciences 46(23):1649-1656, 1990.

189. Pahl, M.V., Erickson, R.A., Vaziri, N.D., Khamiseh, G., Oveisi, F., Jam, K., Seo, J., Kutchemeshgi, M.: Intestinal morphometry and bile acid-induced mucosal injury in chronic experimental renal failure. J. Lab. Clin. Med. 115:572-578, 1990.

190. Yousefi, S., Ghazinouri, A., Vaziri, N.D., Tilles, J., Carandang, G., Cesario, T.: The effect of somatostatin on the production of human interferons by mononuclear cells. Proc. Soc. Exp. Biol. and Med. 194:114-118, 1990.

191. Elias, A.N., Vaziri, N.D., Pandian, M.R., Nawabi, M.A., Khamiseh, G.: Glucose intolerance in renal failure: Role of endogenous opioids. J. Lab. Clin. Med. 116:191-195, 1990.

192. Pahl, M.V., Vaziri, N.D., Seo, M.: Intestinal absorption of carnitine in experimental azotemia. Res. Comm. in Chem. Pathol. and Pharmacol. 70(3):337-347, 1990.

193. Khamiseh, G., Vaziri, N.D., Oveisi, F., Ahmadnia, M., Ahmadnia, L.: Vitamin D absorption, plasma concentration, and urinary excretion of 25-Hydroxyvitamin D in nephrotic syndrome. Proc. Soc. Exp. Biol. and Med. 196:210-213, 1991.

194. Vaziri, N.D., Gonzales, E.V., Barton, C.H., Chen, H.T., Nguyen, Q., Arquilla, M.: Factor XIII and its substrates, fibronectin, fibrinogen, and ?2-antiplasmin, in plasma and urine of patients with nephrosis. J. Lab. Clin. Med. 117:152-156, 1991.

195. Vaziri, N.D., Winer, R.L., Gonzales, E., Phan, Q., Eltorai, I., Hung, E.: Fibronectin and factor XIII in spinal cord injured patients with end-stage renal disease. Paraplegia 28:156-160, 1991.

196. Yousefi, S., Vaziri, N.D., Carandang, G., Le, W., Yamamoto, R., Granger, G., Ocariz, J., Cesario, T.: The paradoxical effects of somatostatin on the bioactivity and production of cytotoxins derived from human peripheral blood mononuclear cells. Br. J. Cancer 64:243-246, 1991.

197. Kaupke, C.J., Vaziri, N.D., Powers, D.R., Gonzales, E.: Erythropoietin in preeclampsia. Obstet. Gynecology 78(5):795-799, 1991.

198. Zhou, X.J., Vaziri, N.D., Kaupke, C.J.: Glomerulopressin in end-stage renal disease: Effect of hemodialysis. ASAIO Journal 37(3):M235-M236, 1991.

199. Vaziri, N.D., Kaupke, C.J., Yousefi, S., Gonzales, E., Cesario, T.C.: Cytokine levels during hemodialysis. ASAIO Journal 37(3):M389-M391, 1991.

200. Cesario, T.C., Vaziri, N.D., Ulich, T.R., Khamiseh, G., Oveisi, F., Rahimzadeh, M., Yousefi, S., Pandian, M.R.: Functional, biochemical, and histopathological consequences of high-dose interleukin-2 administration in rats. J. Lab. Clin. Med. 118(1):81-88, 1991.

201. Elias, A.N., Khamiseh, G., Vaziri, N.D.: Glomerulopressin activity in carbon tetrachloride-induced cirrhosis in male rats. Renal Failure 13(4):253-257, 1991.

202. Pahl, M.V., Barbari, A., Vaziri, N.D., Hollander, D., Yazdani, M., Tran, J., Kan, R.: Intestinal absorption of linoleic acid in experimental renal failure. Br. J. Nutr. 66(3):467-477, 1991.

203. Vaziri, N.D., Kaupke, C.J., Barton, C.H., Gonzales, E.: Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. Am. J. Medicine 92:35-40, 1992.

204. Elias, A.N., Gordon, I., Vaziri, N.D., Chune, G., Pandian, M.R., Gwinup, G., Wesley, R.: Effective portal insulin delivery with enzyme-protected capsules in pancreatectomized pigs. Gen. Pharmacology 23(1):55-59, 1992.

205. Vaziri, N.D., Ismail, M., Martin, D.C., Gonzales, E.: Blood coagulation, fibrinolytic and inhibitory profiles in renal transplant recipients: Comparison of cyclosporine and azathioprine. Int. J. Artif. Organs 15(6):365-369, 1992.

206. Morgan, T.R., Morgan, K., Vaziri, N.D., Pandian, M.R.: Increased glomerular atrial natriuretic peptide receptor affinity in experimental nephrotic syndrome. Life Sciences 51(5):337-344, 1992.

207. Kaupke, C.J., Ahdout, K.J., Vaziri, N.D., Deutsch, L.S.: Perforation of the superior vena cava by a subclavian hemodialysis catheter: Early detection by angiography. Int. J. Artif. Organs 15:666-668, 1992.

208. Said, H.M., Vaziri, N.D., Oveisi, F., Hussienzadha, S.: Effect of chronic renal failure on intestinal transport of biotin in the rat. J. Lab. Clin. Med. 120(3):471-475, 1992.

209. Vaziri, N.D., Eltorai, I., Gonzales, E., Winer, R.L., Pham, H., Bui, T.D., Said, S.: Pressure ulcer, fibronectin and related proteins in spinal cord injured patients. Arch. Phys. Med. Rehabil. 73:803-806, 1992.

210. Zhou, X.J., Vaziri, N.D.: Erythropoietin metabolism and pharmacokinetics in experimental nephrosis. Am. J. Physiol. (Renal Physiol.) 263:F812-F815, 1992.

211. Vaziri, N.D., Kennedy, S.C., Kennedy, D., Gonzales, E.: Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am. J. Medicine 93:651-657, 1992.

212. Elias, A.N., Carreon, G., Vaziri, N.D., Pandian, M.R., Oveisi, F.: The pituitary-gonadal axis in experimental nephrotic syndrome in male rats. J. Lab. Clin. Med. 120:949-954, 1992.

213. Yu, A.W., Zhou, X.J., Zhou, F.Q., Nawab, Z.M., Gandhi, V.C., Ing, T.S., Vaziri, N.D.: Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions. Int. J. Artif. Organs 15:661-665, 1992.

214. Ansari, A., Kaupke, C.J., Vaziri, N.D., Miller, R., Barbari, A.: Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis. Int. J. Artif. Organs 16:31-36, 1993.

215. Kaupke, C.J., Vaziri, N.D.: Effect of recombinant erythropoietin on electrolytes and nutrition in end-stage renal disease patients. Int. J. Artif. Organs 16:59-62, 1993.

216. Vaziri, N.D., Eltorai, I.M., Segal, J.L., Winer, R.L., Gonzales, E., Brunnemann, S., Elmzadeh, M.: Erythropoietin profile in spinal cord injured patients. Arch. Phys. Med. Rehabil. 74:65-67, 1993.

217. Zhou, X.J., Vaziri, N.D., Segal, J.L., Winer, R.L., Eltorai, I., Brunnemann, S.R.: Effects of chronic spinal cord injury and pressure ulcer on 25(OH)-vitamin D level. J. Am. Paraplegia Soc. 16:9-13, 1993.

218. Smith, D.H.G., Vaziri, N.D., Winer, R.L., Neutel, J.M., Graettinger, W.F., Gonzales, E., Weber, M.A.: The relationship of arterial compliance with endothelial-derived proteins of the hemostatic system. Life Sciences 52:1005-1011, 1993.

219. Pahl, M.V., Vaziri, N.D., Kaufman, D.J., Martin, D.C.: Childbirth after renal transplantation. Transplant Proc. 25(4):2727-2731, 1993.

220. Atencio, I.A., Shadan, F.F., Zhou, X.J., Vaziri, N.D., Villarreal, L.P.: Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J. Virology 67:1424-1432, 1993.

221. Hatch, M., Freel, R.W., Vaziri, N.D.: Characteristics of oxalate transport across rabbit proximal colon. Eur. J. Physiol. 423:206-212, 1993.

222. Kaupke, C.J., Butler, G.C., Vaziri, N.D.: Effect of recombinant human erythropoietin on platelet production in dialysis patients. J. Am. Soc. Nephrology 3:1672-1679, 1993.

223. Zhou, X.J., Vaziri, N.D., Kaupke, C.J.: Effects of chronic renal failure and hemodialysis on plasma glomerulopressin. Int. J. Artif. Organs 16:180-184,1993.

224. Vaziri, N.D., Winer, R.L., Gonzales, E.V., Eltorai, I.M.: Fibrinolytic and protease inhibitory systems in spinal cord injured patients with end-stage renal disease. J. Am. Paraplegia Soc. 16(3):149-152, 1993.

225. Vaziri, N.D., Smith, D.H.G., Winer, R.L., Weber, M.A., Gonzales, E., Neutel, J.M.: Coagulation and inhibitory and fibrinolytic proteins in essential hypertension. J. Am. Soc. Nephrology 4(2):222-228, 1993.

226. Vaziri, N.D., Oveisi, F., Wierszbiezki, M., Shaw, V., Sporty, L.D.: Serum melatonin and 6-sulphatoxymelatonin in end-stage renal disease: Effect of hemodialysis. Artif. Organs 17:764-769, 1993.

227. Kaupke, C.J., Zhou, X.J., Vaziri, N.D.: Cytosolic ionized magnesium concentration in ESRD: Effect of hemodialysis. ASAIO Journal 39:M614-M617, 1993.

228. Rhee, P., Waxman, K., Clark, L., Kaupke, C.J., Vaziri, N.D., Tominaga, G., Scannell, G.: Tumor necrosis factor and monocytes are released during hemorrhagic shock. Resuscitation 25:249-255, 1993.

229. Yousefi, S., Karamlou, K., Vaziri, N.D., Carandang, G., Ocariz, J., Cesario, T.: The effect of gonadotropins on the production of human interferon by mononuclear cells. J. Interferon Res. 13:213-220, 1993.

230. Zhou, X.J., Yu, A.W., Zhou, F.Q., Ryu, J., Ing, T.S., Vaziri, N.D.: Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH. Int. J. Artif. Organs 16:816-819, 1993.

231. Ing, T.S., Zhou, X.J, Yu, A.W., Zhou, F.Q., Vaziri, N.D.: Lactate-containing peritoneal dialysis solutions. Int. J. Artif. Organs 16:688-693, 1993.

232. Hatch, M., Freel, R.W., Vaziri, N.D.: Mechanisms of oxalate absorption and secretion across the rabbit distal colon. Eur. J. Physiol. 426:101-109, 1994.

233. Vaziri, N.D., Gonzales, E.C., Wang, J., Said, S.: Blood coagulation, fibrinolytic and inhibitory proteins in end-stage renal disease: Effect of hemodialysis. Am. J. Kidney Dis. 23(6):828-835, 1994.

234. Novey, H.S., Pahl, M., Haydik, I., Vaziri, N.D.: Immunological studies of anaphylaxis to iron dextran in patients on renal dialysis. Ann. Allergy 72:224-228, 1994.

235. Vaziri, N.D., Zhou, X.J., Liao, S.Y.: Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Am. J. Physiol. (Renal Physiol.) 266:F360-F366, 1994.

236. Hatch, M., Vaziri, N.D.: Do thiazides reduce intestinal oxalate absorption?: A study in vitro using rabbit colon. Clin. Sci. 86:353-357, 1994.

237. Kaupke, C.J., Kim, S., Vaziri, N.D.: Effect of erythrocyte mass on arterial blood pressure in dialysis patients receiving maintenance erythropoietin therapy. J. Am. Soc. Nephrology 4:1874-1878, 1994.

238. Vaziri, N.D., Wang, J., Cesario, T., Yousefi, S., Valenzuela, R., Carandang, G.: Induction, transcription, synthesis and adsorption of interleuken-1 by dialyzer membranes. J. Am. Soc. Nephrology 4:1884-1889, 1994.

239. Hatch, M., Vaziri, N.D.: Enhanced enteric excretion of urate in rats with chronic renal failure. Clin. Sci. 86:511-516, 1994.

240. Pahl, M.V., Vaziri, N.D., Gonzales, E.: Coagulation profile in persons with long-standing spinal cord injury. J. Am. Paraplegia Soc. 17(3):133-135, 1994.

241. Vaziri, N.D., Pandian, M.R., Segal, J.L., Winer, R.L., Eltorai, I., Brunnemann, S.: Vitamin D, parathormone and calcitonin profiles in patients with long-standing spinal cord injury. Arch. Phys. Med. Rehabil. 75:766-769, 1994.

242. Vaziri, N.D., Gonzales, E.C., Shayestehfar, B., Barton, C.H.: Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J. Lab. Clin. Med. 124(1):118-124, 1994.

243. Dobos, G.J., Bohler, J., Zhou, X.J., Andre, M., Norgauer, J., Kownatzky, E., Schollmeyer, P.J., Vaziri, N.D.: Persistent inhibition of neutrophil functions by glucose-based dialysis solution. ASAIO Journal 40:M435-M439, 1994.

244. Connall, T.P., Zhang, J., Vaziri, N.D., Kaupke, C.J., Wilson, S.E.: Leukocyte CD11b and CD18 expression are increased in blood salvaged for autotransfusion. Am. Surg. 60:797-800, 1994.

245. Connall, T.P., Zhang, J., Vaziri, N.D., Schwartz, R.J., Kaupke, C.J., Oveisi, F., Wilson, S.E.: Radiodetoxified endotoxin-induced tolerance alters monocyte but not neutrophil CD11b and CD18 expression in response to lipopolysaccharide. Arch. Surg. 129:1153-1158, 1994.

246. Hatch, M., Freel, R.W., Vaziri, N.D.: Intestinal excretion of oxalate in chronic renal failure. J. Am. Soc. Nephrology 5:1339-1343, 1994.

247. Cesario, T.C., Yousefi, S., Carandang, G., Sadati, N., Le, J., Vaziri, N.D.: Enhanced yields of gamma interferon in prolactin treated human peripheral blood mononuclear cells. Proc. Soc. Exp. Biol. Med. 205:89-95, 1994.

248. Zhou, X.J., Yu, A.W., Zhou, F.Q., Wong, F.K.M., Ing, T.S., Vaziri, N.D.: Neutrophilic intracellular pH after exposure of neutrophils to a euhydric, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart. Int. J. Artif. Organs 18:69-72, 1995.

249. Hon, G., Vaziri, N.D., Kaupke, C.J., Tehranzadeh, A., Barton, C.H.: Lack of a fast-acting effect of erythropoietin on arterial blood pressure and endothelin level. Artif. Organs 19(2):188-191, 1995.

250. Vaziri, N.D., Freel, R.W., Hatch, M.: Effect of chronic experimental renal insufficiency on urate metabolism. J. Am. Soc. Nephrol. 6:1313-1317, 1995.

251. Vaziri, N.D., Liang, K.H.: Hepatic HMG-CoA reductase gene expression during the course of puromycin-induced nephrosis. Kidney Int. 48:1979-1985, 1995.

252. Vaziri, N.D., Zhou, X.J., Smith, J., Oveisi, F., Baldwin, K., Purdy, R.E.: In vivo and in vitro pressor effects of erythropoietin in rats. Am. J. Physiol. (Renal Fluid Electrolyte Physiol.) 269(38):F838-F845, 1995.

253. Cinat, M., Waxman, K., Vaziri, N.D., Daughters, K., Yousefi, S., Scannell, G., Tominaga, G.: Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J. Trauma 39:112-118, 1995.

254. Scannell, G., Waxman, K., Vaziri, N.D., Zhang, J., Kaupke, C.J., Jalali, M., Hecht, C.C.: Hypoxia-induced alterations of neutrophil membrane receptors. J. Surg. Res. 59:141-145, 1995.

255. Scannell, G., Waxman, K., Vaziri, N.D., Zhang, J., Kaupke, C.J., Jalali, M., Hect, C.: Effects of trauma on leukocyte intercellular adhesion molecule-1 (ICAM-1), CD11b and CD18 expressions. J. Trauma 39(4):641-644, 1995.

256. Kaupke, C.J., Zhang, J., Cesario, T., Yousefi, S., Akeel, N., Vaziri, N.D.: Effect of hemodialysis on leukocyte adhesion receptor expression. Am. J. Kidney Dis. 27:244-252, 1996.

257. Zhou, X.J., Vaziri, N.D., Pandian, D., Wang, Z.Q., Mazowiecki, M., Liao, S.Y., Oveisi, F.: Urinary concentrating defect in experimental hemochromatosis. J. Am. Soc. Nephrol. 7:128-134, 1996.

258. Hatch, M., Freel, R.W., Shahinfar, S., Vaziri, N.D.: Effects of the specific angiotensin II receptor antagonist, losartan, on urate homeostasis and intestinal urate transport. J. Pharmacol. Exp. Ther. 276:187-193, 1996.

259. Zhang, J., Kaupke, C.J., Cesario, T.C., Vaziri, N.D.: Flow cytometric investigation of neutrophil activation pathways by n-formyl-Met-Leu-Phe and phorbol myristate acetate. Biol. Cell:147-153, 1996.

260. Vaziri, N.D., Wang, Z.Q.: Sustained systemic arterial hypertension induced by extended hypobaric hypoxia. Kidney Int. 49:1457-1463, 1996.

261. Liang, K.H., Oveisi, F., Vaziri, N.D.: Gene expression of hepatic cholesterol 7?-hydroxylase in the course of puromycin-induced nephrosis. Kidney Int. 49:855-860, 1996.

262. Vaziri, N.D., Zhou, X.J., Naqvi, F., Smith, J., Oveisi, F., Wang, Z.Q., Purdy, R.E.: Role of nitric oxide resistance in erythropoietin-induced hypertension in rats with chronic renal failure. Am. J. Physiol. (Endocrinol. Metab.) 271(23):E113-E122, 1996.

263. Meshkinpour, H., Vaziri, N.D., Zhou, X.J., Erickson, R., Liao, S.Y., Oveisi, F., Bemanian, S., Hollander, D.: Effects of experimental hemosiderosis on intestinal morphology, permeability, and tissue iron content. Dig. Dis. Sci. 41(5):984-988, 1996.

264. Vaziri, N.D., Oveisi, F., Reyes, G.A., Zhou, X.J.: Dysregulation of melatonin metabolism in chronic renal insufficiency: Role of erythropoietin-deficiency anemia. Kidney Int. 50:653-656, 1996.

265. Gansevoort, R.T., Vaziri, N.D., de Jong, P.E.: Treatment of anemia of nephrotic syndrome with recombinant erythropoietin. Am. J. Kidney Dis. 28:274-277, 1996.

266. Vaziri, N.D., Liang, K.: Down regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int. 50:887-893, 1996.

267. Rajpoot, D., Kaupke, C.J., Vaziri, N.D., Rao, T.K.S., Pomrantz, A., Fikrig, S.: Childhood AIDS nephropathy: A ten-year experience. J. Natl. Med. Assoc. 88:493-498, 1996.

268. Pahl, M.V., Vaziri, N.D., Oveisi, F., Wang, J.: Antithrombin III inhibits mesangial cell proliferation. J. Am. Soc. Nephrol. 7:2249-2253, 1996.

269. Kaupke, C.J., Zhang, J., Rajpoot, D., Wang, J., Zhou, X.J., Vaziri, N.D.: Effects of conventional peritoneal dialysates on leukocyte adhesion and CD11b, CD18 and CD14 expression. Kidney Int. 50:1676-1683, 1996.

270. Vaziri, N.D., Liang, K.: Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure. Kidney Int. 50:1928-1935, 1996.

271. Pahl, M.V., Wang, J., Zhou, X.J., Wang, X.Q., Tehranzadeh, A., Vaziri, N.D.: Effects of low density lipoprotein on cytosolic [Ca++] in cultured rat mesangial cells. J. Invest. Med. 44:556-560, 1996.

272. Vaziri, N.D., Liang K.: Down regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 51:913-919, 1997.

273. Elias, A.N., Wesley, R.C., Gordon, I.L., Vaziri, N.D.: Effects of adenosine infusion on renal function, plasma, ANP and ADH concentrations and central hemodynamics in anesthetized pigs. Gen. Pharmacol. 28:429-433, 1997.

274. Zhou, X.J., Pandian, D., Wang, X.Q., Vaziri, N.D.: Erythropoietin-induced hypertension in rat is not mediated by alterations of plasma endothelin, vasopressin, or atrial natriuretic peptide. J. Am. Soc. Nephrology 8:901-905, 1997.

275. Liang, K., Vaziri, N.D.: Down regulation of hepatic lipase expression in experimental nephrotic syndrome. Kidney Int. 51:1933-1937, 1997.

276. Liang, K., Vaziri, N.D.: Acquired VLDL receptor deficiency in experimental nephrosis. Kidney Int. 51:1761-1765, 1997.

277. Ing, T.S., Zhou, X.J., Yu, A.W., Zhou, F.Q., Vaziri, N.D.: Effects of pyruvate-based or lactate-based peritoneal dialysis solutions on neutrophil intracellular pH. Int. J. Artif. Organs 20:255-260, 1997.

278. Ni, Z., Morcos, S., Vaziri, N.D.: Up-regulation of renal and vascular nitric oxide synthase in iron-deficiency anemia. Kidney Int. 52:195-201, 1997.

279. Rouse, D., Abramowitz, J., Zhou, X.J., Kamijo, T., Gonzalez, J., Wang, J., Vaziri, N.D., Suki, W.N.: Plasma membrane calcium ATPase isoform expression in cultured rat mesangial cells. Am. J. Physiol. (Renal Physiol.) 273:F76-F83, 1997.

280. Freel, R.W., Hatch, M., Vaziri, N.D.: cAMP-dependent sulfate secretion by the rabbit distal colon: A comparison with electrogenic chloride secretion. Am. J. Physiol. (Cell Physiol.) 273:C148-C160, 1997.

281. Yousefi, S., Vaziri, N.D., Carandang, G., Villaneuva, J.L., Khonsari, S., Ocariz, J., Cesario, T.C.: Platelet-activating factor and the production of human interferon-?. J Interferon Cytokine Res. 17:107-112, 1997.

282. Liang, K., Vaziri, N.D.: Gene expression of LDL receptor, HMG-CoA reductase and cholesterol-7?-hydroxylase in chronic renal failure. Nephrol. Dial. Transplant. 12:1381-1386, 1997.

283. Purdy, R.E., Smith, J.R., Ding, Y., Oveisi, F., Vaziri, N.D., Gonick, H.C.: Lead-induced hypertension is not associated with altered vascular reactivity in vitro. Am. J. Hypertens. 10:997-1003, 1997.

284. Vaziri, N.D., Ding, Y., Ni, Z., Gonick, H.C.: Altered nitric oxide metabolism and increased oxygen free radical activity in lead-induced hypertension: Effect of lazaroid therapy. Kidney Int. 52:1042-1046, 1997.

285. Liang, K., Vaziri, N.D.: Gene expression of lipoprotein lipase in experimental nephrosis. J. Lab. Clin. Med. 130(4):387-394, 1997.

286. Vaziri, N.D., Wang, X.Q., Liang, K.: Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure. Am. J. Physiol. (Renal Physiol.) 273(42):F925-F930, 1997.

287. Seftel, A.D., Vaziri, N.D., Ni, Z., Fogarty, J., Hampel, N., Polak, J., Wang, R.Z., Ferguson, K., Block, C., Haas, C.: Advanced glycation end-products in human penis: Elevation in diabetic tissue, site of deposition and possible effect through iNOS or eNOS. Urology 50:1016-1026, 1997.

288. Gonick, H.C., Ding, Y., Bondy, S.C., Ni, Z., Vaziri, N.D.: Lead-induced hypertension. Interplay of nitric oxide and reactive oxygen species. Hypertension 30:1487-1492, 1997.

289. Hatch, M., Freel, R.W., Vaziri, N.D.: Local upregulation of colonic angiotensin II receptors enhances potassium excretion in chronic renal failure. Am. J. Physiol. (Renal Physiol. 274(43):F275-F282, 1998.

290. Liang, K., Oveisi, F., Vaziri, N.D.: Role of secondary hyperparathyroidism in the genesis of hypertriglyceridemia and VLDL receptor deficiency in chronic renal failure. Kidney Int. 53:626-630, 1998.

291. Baldwin, M.D., Zhou, X.J., Ing, T.S., Vaziri, N.D.: Erythropoietin ameliorates anemia of cisplatin induced acute renal failure. ASAIO J. 44:44-47, 1998.

292. Ding, Y., Vaziri, N.D., Gonick, H.C.: Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside. Environ. Res. 76:107-113, 1998.

293. Vaziri, N.D., Ni, Z., Wang, X.Q., Oveisi, F., Zhou, X.J.: Downregulation of nitric oxide synthase in chronic renal insufficiency: Role of excess PTH. Am. J. Physiol. (Renal Physiol. 43) 274:F642-F649, 1998.

294. Vaziri, N.D., Oveisi, F., Ding, Y.: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 53:1748-1754, 1998.

295. Vaziri, N.D., Ni, Z., Oveisi, F.: Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31:1248-1254, 1998.

296. Tomikawa, M., Ohta, M., Vaziri, N.D., Kaunitz, J.D., Itani, R., Ni, Z., Tarnawski, A.S.: Decreased endothelial nitric oxide synthase in gastric mucosa of rats with chronic renal failure. Am. J. Physiol. (Renal Physiol.) 274(43):F1102-F1108, 1998.

297. Ni, Z., Bemanian, S., Kivlighn, S., Vaziri, N.D.: Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension. Kidney Int. 54:188-192, 1998.

298. Pahl, M.V., Oveisi, F., Khamiseh, G., Vaziri, N.D.: Intestinal absorption and biliary secretion of cholesterol in rats in nephrotic syndrome. Nephrol. Dial. Transplant. 13:1446-1451, 1998.

299. Vaziri, N.D., Ni, Z., Zhang, Y.P., Ruzics, E.P., Maleki, P., Ding, Y.: Depressed renal and vascular nitric oxide synthase expression in cyclosporine-induced hypertension. Kidney Int. 54(2):482-491, 1998.

300. Freel, R.W., Hatch, M., Vaziri, N.D.: Conductive pathways for chloride and oxalate in rabbit ileal brush border membrane vesicles. Am. J. Physiol. 275 (Cell Physiol. 44):C748-C757, 1998.

301. Hatch, M., Freel, R.W., Vaziri, N.D.: Losartan antagonism of angiotensin-II-induced potassium secretion across rat colon. Pflugers Arch. – Eur. J. Physiol. 436:717-724, 1998.

302. Ding, Y., Vaziri, N.D.: Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells. Hypertension 32:718-723, 1998.

303. Ni, Z., Wang, X.Q., Vaziri, N.D.: Nitric oxide metabolism in erythropoietin-induced hypertension: Effect of calcium channel blockade. Hypertension 32:724-729, 1998.

304. Gonick, H.C., Ding, Y., Vaziri, N.D.: Effect of low lead exposure on eicosanoid excretion in rats. Prostaglandins and Other Lipid Mediators 55:77-82, 1998.

305. Enomoto, H., Yousefi, S., Vaziri, N., Khonsari, S., Ocariz, J., Delavarian, M., Cesario, T.: The effect of calcium-related factors on the predominance of IFN-? or interleukin-4 in cultured mononuclear cells. J Interferon Cytokine Res. 18:841-850, 1998.

306. Pelot, D., Zhou, X.J., Carpenter, P., Vaziri, N.D.: Effects of experimental hemosiderosis on pancreatic tissue iron content and structure. Dig. Dis. Sci. 43:2411-2414, 1998.

307. Wang, Z.Q., Liang, K.H., Pahl, M.V., Vaziri, N.D.: Effect of heparin on mesangial cell growth and gene expression of matrix proteins. Nephrol. Dial. Transplant. 13:3052-3057, 1998.

308. Gonick, H.C., Ding, Y., Vaziri, N.D., Bagrov, A.Y., Fedorova, O.V.: Simultaneous measurement of marinobufagenin, ouabain, and hypertension-associated protein in various disease states. Clin. Exp. Hypertens. 20:617-627, 1998.

309. Lehmann, K.G., Vaziri, N.D., Gonzales, E., Tri, B.D.: Systemic and translesional activation of coagulation, fibrinolytic and inhibitory systems in candidates for coronary angioplasty: Basal state and effect of successful dilation. Am. Heart J. 137:274-283, 1999.

310. Vaziri, N.D., Liang, K., Barton, C.H.: Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression. Biochem. Biophys. ACTA 1436:577-584, 1999.

311. Wang, X.Q., Vaziri, N.D.: Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 33:894-899, 1999.

312. Bassa, B.V., Roh, D.D., Vaziri, N.D., Kirschenbaum, M.A., Kamanna V.S.: Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells. Biochem Biophys Acta 1449:137-149, 1999.

313. Vaziri, N.D.: Mechanism of erythropoietin-induced hypertension. Am. J. Kidney Dis. 33:821-828, 1999.

314. Hatch, M., Freel, R.W., Vaziri, N.D.: AT1 receptor up-regulation in intestine in chronic renal failure is segment specific. European J. Physiol. 437:881-887, 1999.

315. Vaziri, N.D., Deng, G., Liang, K.: Hepatic HDL receptor, SR-B1 and Apo A-I expression in chronic renal failure. Nephrol Dial Transplant 14:1462-1466, 1999.

316. Liang, K., Vaziri, N.D.: Down-regulation of hepatic high-density lipoprotein receptor, SR-B1, in nephrotic syndrome. Kidney Int. 56:621-626, 1999.

317. Kamanna, V.S., Bassa, B.V., Vaziri, N.D., Roh, D.D.: Atherogenic lipoproteins and tyrosine kinase mitogenic signaling in mesangial cells. Kidney Int. 56(Suppl. 71):S70-S75, 1999.

318. Bassa, B.V., Roh, D.D., Vaziri, N.D., Kirschenbaum, M.A., Kamanna V.S.: Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLC?-1 and tyrosine kinase-Ras pathways. Am. J. Physiol. (Renal Physiol.) 277:F328-F337, 1999.

319. Vaziri, N.D., Liang, K., Ding, Y.: Increased NO inactivation by reactive oxygen species in lead-induced hypertension. Kidney Int. 56:1492-1498, 1999.

320. Gruber, H.E., Ding, Y., Meyer, M., Pandian, M.R., Pandian, D., Vaziri, N.D., Gonick, H.C.: Adequate dietary calcium mitigates osteopenia induced by chronic lead exposure in adult rats. Miner Electrolyte Metab 25:143-146, 1999.

321. Ni, Z., Oveisi, F., Vaziri, N.D.: Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension 34:552-557, 1999.

322. Vaziri, N.D., Ding, Y., Ni, Z.: Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 34:558-562, 1999.

323. Vaziri, N.D., Wang, X.Q.: cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 34:1237-1241, 1999

324. Hatch, M., Freel, R.W., Vaziri, N.D.: Regulatory aspects of oxalate secretion in enteric oxalate elimination. J. Am. Soc. Nephrology 10:S324-S328, 1999.

325. Ding, Y., Gonick, H.C., Vaziri, N.D.: Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am. J. Hypertens. 13:552-555, 2000.

326. Ding, Y., Vaziri, N.D.: Nifedipine and diltiazem but not verapamil up-regulate endothelial nitric oxide synthase expression. J. Pharmacol. Exp. Ther. 292:606-609, 2000.

327. Sangha, D.S., Vaziri, N.D., Ding, Y., Purdy, R.E.: Vascular hyporesponsiveness in simulated microgravity: Role of nitric oxide-dependent mechanisms. J. Appl. Physiol. 88:507-517, 2000.

328. Ding, Y., Vaziri, N.D., Coulson, R., Kamanna, V.S., Roh, D.D.: Effects of simulated hyperglycemia, insulin and glucagon on endothelial nitric oxide synthase expression. Am. J. Physiol. Endocrinol. Metab.) 279: E11-E17, 2000.
329. Vaziri, N.D., Wang, X.Q., Oveisi, F., Rad, B.: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.

330. Roberts, C.K., Vaziri, N.D., Wang, X.Q., Barnard, R.J.: Enhanced NO inactivation and hypertension induced by a high-fat, refined-carbohydrate diet. Hypertension 36:423-429, 2000

331. Freel, R.W., Vaziri, N.D., Hatch, M.: Muscarinic down-regulation of cAMP-stimulated potassium secretion by rabbit distal colon. European J. Physiol. 440: 243-252, 2000

332. Zhou, X.J., Laszik, Z., Ni, Z., Wang, X.Q., Brackett, D.J., Lerner, M.R., Silva, F.G., Vaziri, N.D.: Downregulation of renal endothelial nitric oxide synthase expression in experimental glomerular thrombotic microangiopathy. Lab. Invest. 80:1079-1087, 2000

333. Vaziri, N.D., Ding, Y., Sangha, D.S., Purdy, R.E.: Selected Contribution: Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. J. Appl. Physiol. 89: 338-344, 2000.

334. Vaziri, N.D., Ni, Z., Trnavsky-Hobbs, D.L.: Effect of antioxidant therapy on blood pressure and nitric oxide synthase expression in hypertensive rats. Hypertension 36:957-964, 2000.

335. Vaziri, N.D., Liang, K., Azad, H.: Effect of cyclosporine on HMG-CoA reductase, cholesterol 7?-hydroxylase, LDL receptor, HDL receptor, VLDL receptor and lipoprotein lipase expressions. J. Pharmacol. Exp. Ther. 294: 778-783, 2000.

336. Zhou, X.J., Laszik, Z., Wang, X.Q., Silva, F.G., Vaziri, N.D.: Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab. Invest. 80:1905-1914, 2000.

337. Ni, Z., Vaziri, N.D.: Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am. J. Hypertens. 14:155-163, 2001.

338. Ding, Y., Gonick, H.C., Vaziri, N.D., Liang, K., Wei, L.: Lead-induced hypertension: Increased hydroxyl radical production. Am. J. Hypertens. 14:169-173, 2001.

339. Vaziri, N.D., Ding, Y.: Effect of lead on NO synthase expression in coronary endothelial cells: Role of superoxide. Hypertension 37:223-226, 2001

340. Barton, C.H., Ni, Z., Vaziri, N.D.: Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression. Kidney Int. 59:654-661, 2001

341. Vaziri, N.D., Liang, K., Parks, J.S.: Acquired Lecithin: Cholesterol acyltransferase (LCAT) deficiency in nephrotic syndrome. Am. J. Physiol. (Renal Physiol) 49: F823-F829, 2001

342. Roberts, C.K., Vaziri, N.D., Liang, K.H., Barnard, R.J.: Reversibility of Experimental Syndrome ? by Dietary modification. Hypertension 37:1323-1328, 2001

343. Pahl, M.V., Culver, B.D., Strong, P.L., Murray, F.J., Vaziri, N.D.: Effect of Pregnancy on Renal Clearance of Boron in Humans: A Study Based on Normal Dietary Intake of Boron. Toxicological Sciences 60:252-256, 2001

344. Vaziri, N.D., Oveisi, F., Culver, B.D., Pahl, M.V., Andersen, M.E., Strong, P.L., Murray, F.J.: Effect of Pregnancy on Boron Renal Clearance in Sprague-Dawley Rats Given Boric Acid Orally. Toxicological Sciences 60:257-263, 2001

345. Vaziri ND. Erythropoietin and transferrin metabolism in nephrotic syndrome. Am. J. Kidney Dis. 38:1-8, 2001

346. Vaziri, N.D., Liang, K., Parks, J.S.: Downregulation of hepatic lecithin:cholesterol acyltransferase (LCAT) gene expression in chronic renal failure. Kidney Int. 59:2192-2196, 2001

347. Deng, G., Vaziri, N.D., Jabbari, B., Ni, Z., Yan, X.X: Increased tyrosine nitration of the brain in chronic renal insufficiency: Reversal by antioxidant therapy and angiotensin-converting enzyme inhibition. J. Am. Soc. Nephrol. 12:1892-1899, 2001

348. Vaziri, N.D., Ding, Y., Ni Z. Compensatory upregulation of NO synthase isoforms in lead- induced hypertension: Reversal by an SOD-minetic drug. J. Pharmacol Exp Ther. 298: 679-685, 2001

349. Barton, C.H., Ni Z., Vaziri ND. Enhanced nitric oxide inactivation in aortic coarctation-induced hypertension. Kidney Int 60:1083-1087, 2001

350. Roberts, C.K., Vaziri, N.D., Barnard, R.J. Protective effects of estrogen on gender specific development of diet-induced hypertension. J Appl. Physiol 91:2005-2009, 2001

351. Sato, T., Liang, K., Vaziri, N.D. Downregulation of lipoprotein lipase and VLDL receptor in rats with focal glomerulosclerosis. Kidney Int 61:157-162, 2002

352. Zhou, X.J., Laszick, Z., Wang, X.Q., Silva, F.G., Vaziri, N.D. Nitric oxide synthase
expression in hypertension induced by inhibition of Glutathione Synthase. J Pharmacol Exp Ther 300: 762-767, 2002
353. Vaziri, N.D., Ni, Z., Oveisi, F., Liang, K. Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency. Hypertension 39:135-141, 2002

354. Roberts, C.K., Barnard, R.J., Liang, K.H., Vaziri, N.D.: Effect of Diet on Adipose Tissue and Skeletal Muscle VLDL Receptor and LPL: Implications for Obesity and Hyperlipidemia. Atherosclerosis 161: 133-141, 2002

355. Vaziri, N.D., Liang, K. Upregulation of acyl-coenzyme A: Cholesterol Acyltransferase (ACAT) in nephrotic syndrome. Kidney Int 61:1769-1775, 2002

356. Attia, D., Ni, Z., Boer, P., Attia, M., Goldschmeding, R., Koomans, H.A., Vaziri, N.D., Joles, J.A.: Proteinuria is preceded by decreased nitric oxide synthesis and prevented by a NO donor in cholesterol-fed rats. Kidney Int 61:1776-1787, 2002

357. Said, H.M., Ortiz, A., Vaziri, N.D. Mechanism and regulation of vitamin B6 uptake by tubular epithelia: studies with cultured OK cells. Am J Physiol, Renal Physiol 282: F465-471, 2002

358. Zhou, X.J., Vaziri, N.D. Defective calcium signaling in uremic platelets and its amelioration with long-term erythropoietin therapy. Nephro Dial Transpl 17:992-997, 2002

359. Roberts, C.K., Vaziri, N.D., Ni, Z., Wang, X.Q., Barnard, J.R. Correction of long-term diet-induced hypertension by dietary modification. Atherosclerosis 163: 321-327, 2002

360. Vaziri, N.D. Pathogenesis of Lead-Induced Hypertension: Role of Oxidative Stress. J of Hypertension 20:S15-S20, 2002

361. Koo, J.R., Oveisi, F., Vaziri, N.D. Antioxidant therapy potentiates antihypertensive action of insulin in diabetes. J Clin Exp Hypertension 24: 333-344, 2002

362. Zhou, X.J, Wang, X.Q., Vaziri, N.D. Association of renal injury with nitric oxide deficiency in aged spontaneously hypertensive rats: prevention by AT-1 receptor blockades. Kidney Int 62: 914-921, 2002.

363. Liang, K., Vaziri, N.D. Upregulation of Acyl-CoA: Cholesterol acyltransferase (ACAT) in chronic renal failure. Am J Physiol: Endocrine and Metab 283:E676-E681, 2002

364. Vaziri, N.D., Wang, X.Q., Kivlighns, S., Shahinfar, S.: Effect of aging and AT-1 receptor blockade on nitric oxide synthase expression in hypertensive rats. Biochem Biophys ACTA 1592:153-161, 2002

365. Roberts CK, Vaziri ND, Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress and nitric oxide availability. Circulation 106:2530-2532, 2002

366. Sharman ES, Vaziri N.D., Ni Z, Sharman KG, Bondy SC. Reversal of Biochemical and behavioral parameters of brain aging by melatonin and acetyl L-carnitine. Brain Research 957: 223-230, 2002

367. Vaziri, N.D., Dicus, M., Ho, N., Sindhu, R. Oxidative stress and dysregulation of superoxide dismutase and NAD(P)H oxidase in renal insufficiency. Kidney Int 63:179-185, 2003

368. Vaziri, N.D., Lin, C.Y., Farmand, F., Sindhu, R.K. Superoxide dismutase, catalase glutathione peroxidase and NAD(P)H in lead-induced hypertension. Kidney Int 63:186-194, 2003

369. Koo, J.R., Vaziri, N.D. Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney Int 63:195-201, 2003

370. Nava M, Quiroz Y, Vaziri ND, Rodriquez-Iturbe B. Melatonin reduces renal interstitial inflammation and improves hypertension in spontaneously hypertensive rats. Am J Physiol-Renal Physiology 284:447-454, 2003

371. Roberts CK, Vaziri ND, Barnard RJ. A high-fat, refined carbohydrate diet Down-Regulates neuronal NO synthase and confers salt sensitivity. J Applied Physiol 94: 941-946, 2003

372. Ma J, Kahwaji CI, Ni Z, Vaziri ND, Purdy RE. Effects of simulated microgravity on nitric oxide synthase expression and nitrate, nitrite content in different arteries of the rat. J Applied Phyiol 94: 83-92, 2003

373. Sindhu, R.K., Vaziri, N.D. Upregulation of cytochrome P450 1A2 in chronic renal failure. Does oxidized tryptophan play a role? Adv Exp Med Biol 527:401-407, 2003

374. Vaziri ND, Sato T, Liang K. Molecular mechanism of altered cholesterol metabolism in focal glomerulosclerosis. Kidney Int 63:1756-1763, 2003

375. Rodriguez-Iturbe B, Zhan C, Quiroz Y, Sindhu RK, Vaziri ND. Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats. Hypertension 41: 341-346, 2003

376. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, Johnson RJ. Microsvascular and tubulointestinal injury associated with chronic hypoxia induced hypertension. Kidney Int 63: 2088-2093, 2003

377. Williams JH, Pahl MV, Kwong D, Zhang J, Hatakeyama D, Ahmad K, Nader M, Kim M, Vaziri ND. Modulation of neutrophil complement receptor-3 expression by pneumococci. Clinical Science 104: 615-625, 2003

378. Liang K, Vaziri ND. HMG-CoA reductase, cholesterol 7?-hydroxylase , LCAT, ACAT, LDL receptor and SR-B1 in hereditary analbuminemia. Kidney Int 64: 192-198, 2003

379. Sato T., Liang K., Vaziri N. D. Protein restriction and AST-120 improve lipoprotein lipase, hepatic lipase and VLDL receptor in focal glomeruloscleros. Kidney Int 64:1780-1786, 2003

380. Ni Z, Vaziri N.D. Downregulation of nitric oxide synthase in nephrotic syndrome: Role of Proteinuria. Biochem Biophys ACTA 1638:129-137, 2003

381. Barton C.H., Ni Z., Vaziri N.D. Blood pressure response to hypoxia: role of nitric oxide synthase. Am J Hypertension 16:1043-1048, 2003

382. Sindhu R.K., Koo J., Roberts C.K., Vaziri N.D. Dysregulation of hepatic superoxide dismutase, catalase and glutathione peroxidase in diabetes: Response to insulin and antioxidant therapies. J Clin Exp Hypertension 26:43-53, 2004

383. Zhan C. D., Sindhu R. K., Vaziri N. D. Upregulations of kidney NAD(P)H oxidase and calcineurin in SHR. Reversal by lifelong antioxidant supplementation Kidney Int 65: 219-227, 2004

384. Vaziri, N.D., Lee, Y.S., Lin, C.Y., Lin, V.W., Sindhu, R.K. NAD(P)H oxidase, superoxide dismutase, glutathione peroxidase and nitric oxide synthase expression in subacute spinal cord injury. Brain Res 995: 76-83, 2004

385. Lee, Y., Sindhu, K., Lin, C.Y., Ehdai, A., Lin, V.W., Vaziri, N.D. Effect of nerve graft on nitric oxide synthase, NAD(P)H oxidase and antioxidant enzymes in chronic spinal cord injury. Free Radical Biol Med 36: 330-339, 2004

386. Lim, C.S., Vaziri, N.D. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int 65:1802-1809, 2004

387. Attia, D.M., Feron, O., Goldschmeding, R., Radermaker, L.H., Vaziri, N.D., Boer, P. Balligand, J., Koomans, H.A., Joles, J.A. Hypercholesterolemia in rats induces podocyte stress and decreases NO synthase via an AT-1 receptor-sensitive mechanism. J Am Soc Nephrol 15:949-957, 2004

388. Koo, J.R., Liang, K., Vaziri, N.D. Microarray analysis altered gene expression in kidneys of adult spontaneously hypertensive rats. J Appl Res 4:111-126, 2004

389. Vaziri, N.D., Dang, B., Zhan, C.D., Liang, K. Downregulation of hepatic Acyl-CoA: diglycerol acyltransferase (DGAT) in chronic renal failure. Am J of Physiol, Renal Physiol 287:F90-94, 2004

390. Vaziri, N.D., Kim, C., Kim, S., Phan, D., Liang, K. Upregulation of hepatic Acyl CoA DGAT-1 expression in nephrotic syndrome. Kidney Int 66: 262-267, 2004

391. Rodriguez-Iturbe, B., Sato, T., Vaziri, N.D. Angiotensin receptor 1 blockade prevents proteinuria, chronic renal failure and hyperlipidemia in the Imai rat. Kidney Int 66:668-675, 2004

392. Vaziri, N.D., Liang, K. Acyl-CoA cholesterol acyltransferase inhibition ameliorates proteinuria, hyperlipidemia, LCAT, SRB-1 and LDL receptor deficiencies in nephrotic syndrome. Circulation 110:419-425, 2004

393. Zhan, C.D., Sindhu, R.K., Ehdaie, A., Pang, J., Vaziri, N.D. Superoxide dismutase, catalase and glutathione peroxidase in the SHR kidney: Effect of antioxidant therapy. J Hypertension 22:2025-2033, 2004

394. Roberts, C. K., Liang, K., Barnard, J. R., Kim, C., Vaziri, N. D. HMG-CoA reductase, cholesterol 7?-hydroxylase, LDL receptor, SRB-1 and ACAT in diet-induced syndrome X. Kidney Int 66:1503-1511, 2004

395. Sindhu, R.K., Vaziri, N.D. Roberts, C.K. Effect of chronic renal failure on caveolin-1, soluble guanylate cyclase and AKt protein expression. Biochem Biophys ACTA 1690: 231-237, 2004

396. Vaziri, N.D., Liang, K. ACAT inhibition reverses LCAT deficiency and improves plasma HDL in chronic renal failure. Am J Physiol, Renal Physiol 287: F1038-F1043, 2004

397. Ni, Z., Hou, S., Barton, C.H., Vaziri, N.D. Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells. Kidney Int 66:2329-2336, 2004

398. Lim, C.S., Vaziri, N.D. Iron and oxidative stress in renal insufficiency. Am J Nephrol 24: 569-575, 2004

399. Rodriguez-Iturbe, B., Quiroz, Y., Ferrebuz, A., Parra, G., Vaziri, N. Evolution of renal interstitial inflammation and NFKB activation in spontaneously hypertensive rats. Am J Nephrology 24:587-594, 2004

400. Vaziri N.D., Liang, K. HMG-CoA reductase inhibition reverses LDL and HDL receptor deficiencies in nephrotic syndrome. Am J Nephrology 24: 606-613, 2004

401. Sindhu, R.K., Roberts, C.K., Ehdaie, A., Zhan, C., Vaziri, N.D. Effects of aortic coarctation on aortic antioxidant enzymes and NADPH oxidase protein expression. Life Sciences 76: 945-953, 2005

402. Roberts, C.K., Barnard, R.J., Sindhu, R.K., Jurezak, M., Ehdaei, A., Vaziri, N.D. A high fat refined carbohydrate diet induces endothelial dysfunction, oxidant/antioxidant imbalance and depressed NO synthase expression. J Appl Physiol 98:203-210, 2005

403. Pahl, M.V., Vaziri, N.D., Connall, T.P., Morrison, D., Kaupke, C.J., Wilson, S.E. Systemic upregulation of leukocyte integrins in response to lower body ischemia-reperfusion during abdominal aortic aneurysm repair. JNMA 97: 172-179, 2005

404. Liang, K., Kim C., Vaziri, N.D. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL metabolism in rats with chronic renal failure. Am J Physiol, Renal Physiol 288:F539-F544, 2005

405. Kim, C., Vaziri, N.D.: Downregulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure. Kidney Int 67:1028-1032, 2005

406. Vaziri, N.D., Ding, Y., Ni, Z., Barton, C.H. Bradykinin downregulates whereas arginine analogues upregulate eNOS expression in coronary endothelial cells. J Pharmacol Exp Ther 313:121-126, 2005

407. Balamurugan, K., Vaziri, N.D., Said, H. Biotin uptake by human proximal tubular epithelial cells: Cellular and molecular aspects. Am J Physiol, Renal Physiol 288:823-831, 2005

408. Kim, S., Kim, C., Vaziri, N.D. Upregulation of hepatic LDL receptor-related protein (LRP) in nephrotic syndrome: Response to statin therapy. Am J Physiol, Endocrinol Metab 288:E813-E818, 2005

409. Kim, C., Vaziri, N.D. Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int 67:1462-1470, 2005

410. Adams, G.R., Zhan, C., Haddad, F., Vaziri, N.D. Voluntary exercise during chronic renal failure in rats. Medicine and Science in Sport and Exercise 37:557-562, 2005.


411. Sindhu,R.K., Ehdaei A., Farmand F., Dhaliwal K., Nguyen T., Zhan CD.,Roberts C.K., Vaziri ND. Expression of catalase and glutathione peroxidase in renal insufficiency. Biochim Biophys Acta 1743:86-92, 2005

412. Xu, Z. Lanting, L., Vaziri, N.D., Li, Z., Sepassi, L., Rodriguez-Iturbe, B., Natarajan, R. Upregulation of Ang II Type I receptor, inflammatory mediators and enzymes of arachidonate metabolism in obese Zucker rat kidney: Reversal by Ang II Type I receptor blockade. Circulation 111:1962-1969, 2005

413. Vaziri, N.D., Ni, Z. Expression of NOX-1, gp91phox¬, p47phox and p67phox in the aorta segments above and below coarctation. Biochem Biophys ACTA 1723: 321-327, 2005

414. Rodriguez-Iturbe, B., Ferrebuz, A., Vanegas, V., Quiroz, Y., Vaziri, N.D. Early and sustained inhibition of nuclear factor Kappa B prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther ; 315 : 51-57, 2005

415. Rodriquez-Iturbe, B., Quiroz, Y., Kim, C.H., Vaziri, N.D. Hypertension induced by aortic coarctation above the renal arteries is associated with immune cell infiltration of the kidneys. Am J Hypertension 18:1449-1456, 2005

416. Rodriguez-Iturbe, B., Sindhu, R.K., Quiroz, Y., Vaziri, N.D. Chronic exposure to low doses of lead results in renal infiltration of immune cells, apoptosis, NFKB activation and overexpression of tubulointerstitial angiotensin II. Antioxidants and Redox Signaling 7: 1269-1274, 2005

417. Rodriquez-Iturbe, B., Quiroz, Y., Shahkarami, A., Li, Z., Vaziri, N.D. Mycophenolate mofetil ameliorates nephropathy in the obese Zucker rats. Kidney Int 68: 1041-1047, 2005

418. Rodriguez-Iturbe, B., Ferrebuz, A., Quiroz, Y., Nanegas, V., Espinoza, F., Vaziri, N.D. Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage. Kidney Int 68: 2131-2142, 2005.

419. Shin, S., Vaziri, N.D., Willkers, N., Kim, C.H., Joles, J.A. Effects of gender on hepaticHMG-CoA reductase, cholesterol 7a-hydroxylase and LDL receptor in hereditary analbuminemia. Am J Physiol, Endocrinol Metab 289: E993-E9998, 2005.

420. Vaziri, N.D., Xu, Z., Shahkarami, A., Huang, K.T., Rodriguez-Iturbe, B., Natarajan, R. Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP Kinase and matrix expressions in obesity. Kidney Int 68: 2787-2793, 2005

421. Li, Z., Rodriguez-Iturbe, B., Ni, Z., Shahkarami, A., Sepassi, L., Vaziri, N.D. Effect of hereditary obesity on renal expression of NO synthase, caveolin-1, Akt, guanylate cyclase and calmodulin. Kidney Int 68: 2766-2772, 2005

422. Molero L, Carrasco C, Marques M, Vaziri ND, Mateos-Caceres PJ, Casado S, Macaya C, Barrientos A, Lopez-Farre AJ. Involvement of endothelium and endothelin-1 in lead-induced smooth muscle cell dysfunction in rats. Kidney Int 69: 685-690, 2006

423. Roberts, C.K.,Won, D., Pruthi, S., Kurtovic, S., Sindhu, R.K., Vaziri, N.D., Barnard, R.J. Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9 and monocyte chemotactic activity in men with metabolic syndrome. J Appl Physiology 100:1657-1665, 2006

424. Pech, V., Sikka S.C., Sindhu, R.K., Vaziri, N.D., Majid, D. Oxidant stress and blood pressure responses to angiotensin II administration in rats fed on varying salt diets. Am J Hypertension 19: 534-540, 2006

425. Roberts, C.K, Barnard, R.J., Sindhu, R.K., Jurczak, M., Ehdai, A, Vaziri, N.D. Endothelial dysfunction, oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome. Metabolism. 55: 928-934, 2006

426. Moradi, H., Kwok, V., Vaziri, N.D. Effects of Chronic Renal Failure on Arginase and argininosuccinate Syntethase expression. Amer J Nephrol 26: 310-318, 2006

427. Yoon, J.W., Gollapudi, S., Pahl, M.V., Vaziri, N.D. Naïve and Central Memory T cell Lymphopenia in End-Stage Renal Disease Kidney Int 70: 371-376, 2006

428. Ashokumar, B., Vaziri, N.D., Said, H.M. Thiamin uptake by the human-derived renal epithelial (HEK-293) cells: cellular and molecular mechanisms. Am J Physiol, Renal Physiol 291: F796-805, 2006

429. Bevers, L.M., van Faassen, E.E., Voung, T.D., Ni, Z., Boer, P., Kooman, H.A., Braam, B., Vaziri, N.D., Joles, J. Low albumin level increases endothelial NO and decreases NO sensitivity. NDT 21: 3443-3449,2006

430. Yoon, J.W., Pahl, M.V., Vaziri, N.D. Spontaneous leukocyte activation and oxygen-free radical generation in end stage renal disease. Kidney Int 71: 167-172, 2007

431. Rodriguez-Iturbe, B., Sepassi, L., Quiroz, Y., Ni, Z., Vaziri, N.D. Association of mitrochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 155-160, 2007

432. Campese, V., Sindhu, R. K., Ye, S., Vaziri, N. D., Jabbari, B. Regional expression of NO synthase, NAD(P)H oxidase and superoxide dismutase in the rat brain. Brain Research 1134: 27-32, 2007

433. Bai Y., Ye, S., Mortazavi, R., Campese V., Vaziri, N.D. Effect of Renal Injury-induced Neurogenic Hypertension on NO Synthase, Caveolin-1, AKt, Calmodulin, Soluble Guanylate Cyclase and Phosphodiesterase Expression. Amer J Physiol, Renal Physiol 292: F974-980, 2007

434. Subramanian V. S., Mohammed Z. M., Molina A., Marchant J. S., Vaziri N.D., Said H. M. Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: Mechanism and regulation. J Physiol 582: 72-85, 2007

435. Ashokkumar B., Mohammed Z.M., Vaziri N.D., Said H.M. Effect of folate over-supplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 86(1):159-66. 2007

436. Kim C. H., Vaziri N. D., Rodriguez-Iturbe B.Increased Integrin Expression and H2O2 production by circulating and splenic leukocytes in the obese Zucker rats. J Obesity 15(9):2209-2216. 2007

437. Vaziri N. D., Bai Y.,Ni Z., Quiroz Y., Rodriguez-Iturbe B.Intra-renal angiotensin II/AT1 Receptor, Oxidative Stress, Inflammation and Progressive Injury in Renal Mass Reduction. J Pharmacol Exp Ther 323(1):85-93, 2007

438. Kim C.H., Kim H.J., Mitsuhashi M., Vaziri N. D. Hepatic tissue Sterol Regulatory Element-Binding Protein-2 (SREBP-2) and LDL receptor in Nephrotic Syndrome. Metabolism 56: 1377-1382, 2007

439. Bravo J., Quiroz Y., Ferrebuz A., Vaziri N.D. Rodríguez-Iturbe B. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress and hypertension in lead-exposed rats chronically. Am J Physiol,Renal Physiol 293(2):F616-F623, 2007

440. Chandramohan G., Bai Y., Norris K., Vaziri N.D. Effects of Dietary Salt on Intrarenal Angiotensin System, NAD(P)H Oxidase, COX-2 , MCP-1 and PAI-1 Expressions and NFkB activity in Salt-Sensitive and -Resistant Rat Kidneys. Am J Nephrol 28: 158-167, 2008

441. Zhen JH, Lu H. , Wang XQ. Vaziri N.D., Zhou X. J. Up-regulation of endothelial and inducible nitric oxide synthase by reactive oxygen species Am J Hypertension. 21(1):28-34, 2008

442. Shelkovnikov S., Summer ,S. Adams G, Purdy,R.E. Vaziri N.D. Effect of exercise training on aortic tone in chronic renal failure. Am J Hypertension 21:564-569, 2008

443. Quiroz Y., Romero F., Ferrebuz A., Vaziri N. D., Rodríguez-Iturbe B. Melatonin ameliorates oxidative stress, inflammation, proteinuria and progression in rats with renal mass reduction . Am J Physiol, Renal Physiol 294: F336-344, 2008

444. Said ZM, Subramanian VS, Vaziri ND, Said HM. Pyridoxine uptake by colonocytes: A specific and regulated carrier-mediated process. Am J Physiol, Cell Physiol 294:1192-1197, 2008

445. Delfino RJ, Staimer N, Tjoa T, Polidori A, Arhami M, Gillen D, Kleinman MT, Vaziri ND, Longhurst J, Zaldivar F, Sioutas C. Circulating biomarkers of inflammation, antioxidant activity, and platelet activation are associated with primary combustion aerosols in subjects with coronary artery disease. Environ Health Perspective 116:898-906, 2008

446. Bai Y., Sigala W. , Adams G., Vaziri N. D. Effect of Exercise on Cardiac Tissue AT1 Receptor, NAD(P)H Oxidase, Cyclooxygenase, MCP-1 and PAI-1 in Chronic Renal Insufficiency. Am J Nephrol 29:213-221, 2009

447. Bai Y, Jabbari B, Ye S,. Campese VM, Vaziri ND. Regional Expression of NAD(P)H Oxidase and Superoxide Dismutase in the Brain of Rats with Neurogenic Hypertension. Am J Nephrol 29:483-492, 2009

448. Kamgar M, MD, Zaldivar F, Vaziri ND, Pahl MV. Antioxidant Therapy Does Not Ameliorate Oxidative Stress and Inflammation in End-Stage Renal Disease Patients. JNMA 101(4):336-44. 2009

449. Kim HJ, Vaziri ND. Sterol Regulatory Element-Binding Proteins, Liver X-Receptor, ABCA1 Transporter, CD36, Scavenger Receptors A1 And B1 In Nephrotic Kidney. Am J Nephrol 29:607–614, 2009

450. Wonsuk A, Kim SE, Kim KH, Lee S, Park Y, Kim H, Vaziri ND. Comparison of fatty acid contents of erythrocyte membrane in hemodialysis and peritoneal dialysis patients. J Renal Nutri 19: 267-74, 2009

451. Chandramohan G, Durham, N. Norris K. Vaziri N.D. Dysregulation of Renal Melanocortin 3 Receptor in hereditary Salt Sensitive Hypertension. Metabolism 58(10):1424-9, 2009

452. Lee Y, Koo JR, Kim JK, Park I, Joo MH, Yoon JW, Noh JW, Vaziri ND. Effect of the route of erythropoietin administration on prevalence of vascular access failure in hemodialysis patients. Am J Kidney Dis 53 : 815-822, 2009 (subject of an editorial review in Aug issue of Nature reviews Nephrol)

453. Wolak T., Kim, H.J. Ren, Y. Kim, J. Vaziri, N. D. Nicholas. S. B. Osteopontin modulates Angiotensin II-induced renal inflammation, oxidative stress, epithelial-mesanchymal transition and fibrosis. Kidney International 76(1):32-43, 2009

454. Delfino RJ, Staimer N, Tjoa T, Gillen D, Polidori A, Arhami M, Kleinman MT, Vaziri ND, Longhurst J, Sioutas C. Air pollution exposures and circulating biomarkers of effect in a susceptible population: clues to potential causal component mixtures and mechanisms. Environ Health Perspective 117:1232–1238, 2009

455. Pahl MV, Ni Z, Sepassi L, Vaziri ND. Plasma Phosphlipid Transfer Protein, Cholesteryl Ester Transfer Protein and Lecithin: Cholesterol Aacyltransferase in End-StageE Renal Disease. NDT 24(8):2541-6, 2009.

456. Moradi H, Pahl MV., Elahimehr R,Vaziri ND. Impaired Antioxidant Activity of HDL in Chronic Kidney Disease. Translational Research. 153: 77-85, 2009

457. Kim HJ, Moradi H, Vaziri ND. Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol, Renal Physiol . 296(6):F1297-306, 2009

458. Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide Kidney Int 76(4):437-44, 2009 (subjet of an editorial review in same issue of the journal)

459. Moradi H, YuanJ, Ni Z, Norris K, Vaziri ND. Reverse cholesterol transport pathway in experimental chronic kidney disease. Am J Nephrol 30:147–154, 2009

460. An WS, Kim HJ, Cho KH, Vaziri ND. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation and tubulo-interstitial fibrosis in the remnant kidney. Am J Physiol, Renal Physiol 297(4): F895-903, 2009

461. Quiroz Y, Ferrebuz A, Vaziri ND, Rodriguez-Iturbe B. Effect of Chronic Antioxidant Therapy with Superoxide Dismutase-Mimetic Drug, Tempol, on Progression of Renal Disease in Rats with Renal Mass Reduction. Nephron Exp Nephrol ;112(1):e31-e42, . 2009

462. Cho K, Kim H, Rodriguez-Iturbe B, Vaziri ND. Niacin Ameliorates Oxidative Stress, Inflammation, Proteinuria, And Hypertension In Rats With Chronic Renal Failure Am J Physiol, Renal Physiol 297(1):F106-13, 2009 (Featured on the cover of AJPfor 5 conseutive issues)

463. Aminzadeh A, Pahl MV, Barton C H,. Vaziri ND. Human uremic plasma stimulates release of leptin and uptake of tumor necrosis factor-a in visceral adipocytes. NDT 24(12):3626-31, 2009

464. Cho K, Kim H, VS Kamanna, Vaziri ND. Niacin improves renal lipid metabolism and slows progression in chronic kidney disease. Biochim Biophys ACTA 1800: 6–15, 2010

465. Pahl MV , Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of End-Stage Renal Disease on Subpopulations of Circulating B Lymphocytes. NDT 25(1):205-212, 2010

466. Pahl MV YuanJ, Vaziri ND , Adler S. Upregulation of monocyte/macrophage HGFIN expression in end-stage renal disease. CJASN 5: 56-61, 2010

467. Agrawal S, Pahl MV, Vaziri N.D. Effects of end-stage renal disease and hemodialysis on dendritic cell subsets and basal and LPS-stimulated activity
NDT. 25: 737-46, 2010
468. Kim HJ, Vaziri ND. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Am J Physiol, Renal Physiol 298(3):F662-671, 2010

468. Yaguas K, Bautista R, Quiroz Y, Ferrebuz, Pons H, Franco Martha, Vaziri N D, Rodriguez-Iturbe B. Chronic inhibition of CGMP phosphodiesterase ameliorates hypertension and corrects endothelial dysfunction in spontaneously hypertensive rats. Am J Nephrol 31:283-291, 2010.

469. Gollapudi P, Yoon J-W, Gollapudi S, Pahl MV, Vaziri ND. Effect of End Stage Renal Disease and Hemodialysis on Expression and Activities of Leukocyte Toll-like Receptors (TLR). Am J Nephrology 31:247-254, 2010

470. Kim HJ, Yuan J, Norris K, Vaziri ND. High calorie diet partially ameliorates dysregulation of intra-renal lipid metabolism in the remnant kidney. Nutritional Biochemistry 21: 999-1007, 2010

471. Sinha-Hikim I, Shen R, Kovacheva E, Paul Lee, Crum A, Vaziri ND, Norris K. Inhibition of apoptotic signaling in spermine-treated vascular smooth muscle cells by a novel cystine based glutathione precursor. Cell Biology Int 34(5):503-11, 2010

472. Moradi H, Ganji S, Kamanna Vj, Pahl MV, ND. Vaziri. Increased Monocyte Adhesion-Promoting Capacity of Plasma in End-Stage Renal Disease - Response to Antioxidant Therapy. Clinical Nephrology. 74(4):273-281, 2010

473. Vaziri ND, Kim HJ, Moradi H, Navab K, Farmand F, Quirox Y, Navab M Rodriguez-Iturbe B. Amelioration of nephropathy with ApoA-1 mimetic peptide in apoE-deficient mice. NDT 25(11):3525-34, 2010


474. Vaziri ND, Bai Y, Yuan J, Said H, Sigala W, Ni Z. ApoA-1 mimetic peptide reverses uremia-induced up-regulation of pro-atherogenic pathways in the aorta. Am J Nephrology 32(3):201-211, 2010

475. Sinha-Hikim I, Shen R, Kovacheva E, Paul Lee, Crum A, Vaziri ND, Norris K. A novel cystine based glutathione precursor protects vascular smooth muscle cells against spermine-induced oxidative stress and apoptosis. Am J Physiol, cell Physiol 299(3):C638-642, 2010

476. Lu H, Wu T, Wang T, Yu X, Vaziri N. D., Mohan C.. Zhou X. J. Superoxide dismutase mimetic drug, tempol, aggravates anti-GBM antibody induced glomerulonephritis in mice. Am J Physiol, Renal Physiol 299:445-452, 2010.

477. Kim HJ, Vaziri ND, Norris K, Quiroz Y, Rodriguez-Iturbe B. High calorie diet prevents cachexia and ameliorates oxidative stress, inflammation and proteinuria in experimental CKD. Clin Exp Nephrol 14(6):536-47, 2010

478. An WS, Kim S-E, Kim K-H, Bae H-R, Lee S, Park Y, Kim HJ, Vaziri ND Association of adiponectin and leptin with serum lipids and erythrocyte omega-3 and omega-6 fatty acids in dialysis patients. Clinical Nephrology 75(3):195-203. 2011

479. Aminzadeh MA, Gollapudi P, Vaziri, ND. Effect of nephrotic syndrome on homocysteine metabolism. NDT, 26(4):1244-1247, 2011

480. Vaziri ND, Moradi H, Barton CH, Pahl MV, Navab M. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. JNMA 103(6):524-33, 2011

481. Bukhari F J, Moradi H, Kim HJ,. Vaziri ND, Said HM. Effect of chronic kidney disease on the expression of Thiamin and Folic acid transporters. NDT 26:2137-44, 2011

482. Vaziri ND, Gollapudi p, Han S, Farahmand G, Moradi H. Upregulation of hepatic HDL endocytic receptor and PDZK-1 dependent downregulation of HDL docking receptor in nephrotic syndrome. NDT 103(6):524-33, 2011

483. Kim HJ, Sato , Rodriguez-Iturbe B, Vaziri ND. Role of intra-renal angiotensin system activation, oxidative stress, inflammation and impaired Nrf2 activity in the progression of focal glomerulosclerosis. JPET 337(3):583-90, 2011

484. Peng A, Ye T, Rakheja D, Hu Z, Tu Y, Wang T, Du Y, Vaziri ND, Mohan C, Zhou XJ. Green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) ameliorates experimental immune-mediated glomerulonephritis. Kidney Int; 80(6):601-611, 2011

485. Sinha-Hikim I, Sinha-Hikim AP, Shen R, Kim H, French SW, Vaziri ND, Crum A, Rajavashisth TB, Norris KC. A Novel Cystine Based Antioxidant Attenuates Oxidative Stress and Hepatic Steatosis in Diet-Induced Obese Mice. Experimental and Molecular Pathology 91(1):419-428, 2011

486. Peng A, Wu T, Zeng C, Rakheja D, Liu Z, Vaziri ND, Mohan C, Zhou XJ. Adverse effects of simulated hyper- and hypo-phosphatemia on endothelial cell function and viability. PLoS One 6(8): e23268. doi:10.1371/journal.pone.0023268, 2011

487. Kamanna VS, Ganji SH, Shelkovnikov S, Norris K,Vaziri ND. Iron sucrose promotes endothelial injury and dysfunction and monocyte adhesion/infiltration. Am J Nephrol Dec 29;35(2):114-119, 2011

488. Lee HJ, Pahl MV, Vaziri ND,. Blake DR. Effect of hemodialysis and diet on the exhaled breath methanol concentration in patients with ESRD. J Renal Nutrition J Ren Nutr. 22, No 3: 357–364, 2012

489. Aminzadeh MA, Vaziri ND. Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease. NDT 27(2):498-504, 2012

490. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: A likely cause of CKD-associated inflammation. Nephrol Dial Transplant. 27(7):2686-93, 2012 (selected by the Faculty of 1000 as one of the top 2% of published papers in Medicine and Biology)

491. Vaziri ND, Yuan J, Ni Z, Nicholas SB, Norris, KC. Lipoprotein lipase deficiency in chronic kidney disease is compounded by downregulation of endothelial GPIHBP1 expression. Clin Exp Nephrol 16:238–243, 2012

492. Lee JH, Meinardi S, Pahl MV, Vaziri ND, Blake DR. Exposure to Potentially Toxic Hydrocarbons and Halocarbons released from Dialyzer and Tubing set during Hemodialysis. Am J Kidney Disease Oct;60(4):609-16. 2012

493. Aminzadeh AM, Sato T, Vaziri ND. Participation of endoplasmic reticulum stress in the pathogenesis of spontaneous glomerulosclerosis –Role of intra-renal angiotensin system. Translational Research, 160 (4):309-18 2012

494. Ichii H, Masuda Y, Hassanzadeh T, Saffarian M, SV Gollapudi, ND Vaziri. Iron sucrose impairs phagocytic function and promotes apoptosis in polymorphonuclear leukocytes. Am J Nephrology 36:50–57, 2012

495. Chandramohan G, Kalantar-Zadeh K, Kermah D, Go SCM, Vaziri ND, Norris K. relationship between obesity and pulse pressure in children: Results of the National Health and Nutrition Survey (NHANES) 1988-1994. J Am Soc Hypertension 6(4):277-83, 2012
496. Reisman SA, Chertow GM, Hebbar S, Vaziri ND, Ward KW, Meyer C J. Bardoxolone Methyl Decreases Megalin and Activates Nrf2 in the Kidney. J Am Soc Nephrol 23(10):1663-73, 2012 (selected by the Faculty of 1000 as one of the top 2% of published papers in Medicine and Biology)

497. Nicholas SB, Yuan J, Aminzadeh AM, Norris K, Crum A, Vaziri ND. Salutary effects of a novel oxidative stress modulator on adenine-induced chronic progressive tubulointerstitial nephropathy. Am J Translational Res 4(3):257-68, 2012

498. Vaziri ND, Goshtasby N, Yuan J, Jellbauer S, Moradi H, Raffatellu M, r Kalantar-Zadeh K. Uremic human plasma degrades intestinal epithelial barrier structure and function. Am J Nephrology 36(5):438-443, 2012

499. Moradi H, Said HM, Vaziri ND. Post-Transcriptional Nature of Uremia-induced Down-Regulation of hepatic Apolipoprotein A-I production. Transl Research [Epub ahead of print]PMID: 23219399; 2012

500. Vaziri ND, Yuan J, Norris K. Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in CKD. Am J Nephrology 37(1):1-6. 2012

501. Meinardi S, Jin KB, Blake DR. Vaziri ND. Novel gaseous breath and fecal biomarkers of CKD. Biochim Biophys ACTA 1830(3):2531-2537, 2012

502. Vaziri ND, Wong J, Pahl MV, Piceno YM, Yuan J, DeSantis TZ, Ni Z, Nguyen TH, Andersen GL. Chronic kidney disease alters the composition of intestinal microbial flora . Kidney Int 83(2):308-15 2013 (selected by the Faculty of 1000 as one of the top 2% of published papers in Medicine and Biology)

503. Jin K, Norris K, Vaziri ND. Dysregulation of hepatic fatty acid metabolism in chronic kidney disease. Nephrol Dial Transplant. 28(2):313-20; 2013

504. Lee YK, Lee DH, Kim JK, Park MJ, Yan JJ, Song DK, Vaziri ND, Noh JW Lysophosphatidylcholine, Oxidized Low-Density Lipoprotein and Cardiovascular Disease in Korean Hemodialysis Patients: Analysis at 5 Years of Follow-up. J Korean Med Sci. Feb;28(2):268-73. 2013

505. Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris G L, Chin M, Krauth Melissa, Heerspink H JL, Meyer CJ, McMurray JJ, Parving H-H, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM. Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes: the Occurrence of renal eveNts (BEACON): Rationale and Trial Design Am J Nephrology 37(3):212-222; 2013

506. De Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Goldsberry A, Houser M, Krauth M, Lambers Heerspink H., Meyer CJ, McMurray JJ, Parving H, Remuzzi G, Christ-Schmidt H, Wrolstad D, Toto RD, Vaziri ND, Wanner C, Wittes J, Chertow GM. The Effect of Bardoxolone Methyl in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease: Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) Trial. New England Journal Medicine 369(26):2492-503, 2013

507. Han SY, Vaziri ND, Gollapudi P, Kwok V, Moradi H. Hepatic fatty acid and cholesterol metabolism in nehprotic syndrome. Am J Transl Research 5(2):246-53, 2013

508. Aminzadeh M A, Nicholas SB., Norris KC., Vaziri ND.. Role of impaired Nrf2 activation in the pathogenesis of oxidative stress and inflammation in chronic tubulo-interstitial nephropathy. Nephrol Dial Transplant 28(8):2038-45, 2013

509. Vaziri ND, Yuan J, Khazaeli M, Masuda Y, Ichii H, Liu S. Oral activated charcoal adsorbent (AST-120) ameliorates CKD-induced intestinal epithelial barrier disruption and systemic inflammation. Amer J Nephrol 37:518–525, 2013

510. Vaziri ND, Yuan J, Nazertehrani S, Ni Z, Liu S. Chronic kidney disease causes disruption of gastric and small intestinal epithelial tight junction. Amer J Nephrol 38(2):99-103, 2013

511. Heerspink HJ L, Chertow G, Akizawa T, Audhya P, Bakris GL, Goldsberry A, Krauth M, Meyer CJ, McMurray J, Parving HH, Remuzzi G, Christ-Schmidt H, Wrolstadt D, Stolzenbach James, Toto RD., Vaziri ND, Wanner C, Wittes J, de Zeeuw D. Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal events (BEACON) trial. Nephrol Dial Transplant 28(11):2841-50, 2013

512. Yazdi PG, Moradi H,Yang IY, Wang PH,Vaziri ND, Skeletal muscle mitochondrial depletion and dysfunction in chronic kidney disease. Int J Clin Exp Medicine 6 (7):532-539, 2013

513. Aminzadeh MA, Reisman SA, Vaziri ND, Shelkovnikov S, Farzaneh SH , Khazaeli M, Meyer CJ. Role of impaired Nrf2 activity in Chronic Kidney Disease-induced endothelial dysfunction and its restoration with the Synthetic Triterpenoid RTA dh404. Redox Biology 1:527–531,2013

514. MasudaY, Ichii H, Vaziri. At pharmacologically relevant concentrations intravenous iron preparations cause pancreatic beta cell death. American J Transl Res 6(1):64-70, 2013

515. Jin K, Vaziri N. Salt-sensitivity and oxidative stress in MnSOD-deficient mice is associated with activation of NFkB and upregulation of NAD(P)H oxidase in the kidney Clin Exp Nephrol, 18(3):445-52, 2014


516. Jin KB, Park BS, Kim YW, Vaziri ND. Hypercholesterolemia in nephrotic and peritoneal dialysis patients is associated with elevated plasma PCSK9 level. Am J Kidney Dis 63(4):584-9, 2014

517. Liu S, Vaziri ND. Role of PCSK9 and IDOL in the pathogenesis of acquired LDL receptor deficiency and hypercholesterolemia in nephrotic syndrome Nephrol Dial Transplant 29(3):538-43, 2014

518. Aminzadeh MA , Reisman SA, Vaziri ND., Yuan J, Khazaeli M, Meyer CJ..The Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Restores Nrf2 Activity and Attenuates Oxidative Stress, Inflammation, and Fibrosis in Rats with Chronic Renal Failure. Xenobiotica 44(6):570-8, 2014

519. Chin MP., Agarwal R, Bakris GL, Goldsberry A, Linde PG., McCullough PA., McMurray JJ, Packham D, Pergola PE, Reisman SA, Christ-Schmidt H, Vaziri ND, Warnock DG., Wittes J, Wrolstad D, Meyer CJ. Heart Failure in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: the Occurrence of renal eveNts (BEACON) Trial Amer J Nephrol 39(6):499-508, 2014

520. Wong J, Piceno YM, DeSantis TZ, Pahl M, Andersen GL, Vaziri ND. Expansion of urease and uricase-containing, indole- and p-cresol-forming and contraction of short chain fatty acid-producing intestinal bacteria in ESRD American Journal Nephrol 39:230–237, 2014

521. Moradi H, Kashyap M, Streja E, Vaziri ND, Kalantar-zadeh K. Elevated HDL cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant 29(8):1554-62, 2014

522. Lau WL Liu S; Vaziri ND. Chronic kidney disease results in deficiency of ABCC6, the novel inhibitor of vascular calcification. Am J Nephrol ;40(1):51-55, 2014

523. Robles L, Vaziri ND; Li S, Masuda Y, Takasu C, Vo K, Farzaneh S, Stamos M, Ichii H. Dimethyl Fumarate protects pancreatic islet cells and non-endocrine tissue in L-Arginine-induced chronic pancreatitis. PLoS-One 9(9):e107111. doi: 10.1371, 2014

524. Masuda Y; Vaziri ND; Chie Takasu C; Li S; Robles L; Pham C; Le A; Vo K; Farzaneh S, Stamos M, Ichii H. Salutary effect of pre-treatment with an Nrf2 inducer on ischemia reperfusion injury in the rat liver. Gastroenterol Hepatol. 1(1):1-7, 2014

525. Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Farzaneh SH, Kieffer D, AdamS S, Martin R. High amylose resistant starch diet ameliorates oxidative stress, inflammation, and progression of chronic kidney disease. PLoS-One, 9(12):e114881. doi: 10.1371/journal.pone.0114881. eCollection.PMID: 25490712, 2014

526. Son YK; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli,K, Vaziri ND. Nrf2 activator, dh404, restores renal Klotho expression and attenuates oxidative stress and inflammation in rats with chronic kidney disease. J Applied Health Sci Int 2(1): 22-34, 2015

527. Li S, Vaziri ND, Masuda Y, Hajighasemi-Ossareh M, Robles L, Le A, Vo K, Chan JY, Foster CE., Stamos MJ, Ichii H. Pharmacological activation of Nrf2 pathway improves pancreatic islet isolation and transplantation. Cell Transplantation. [Epub ahead of print] PMID:25581574, 2015

528. Moradi H, Streja E, Kashyap M, Shah G, Gillen D, Pahl M, MD, Vaziri ND, Kalantar-Zadeh K. Association of Serum Lipids with Outcomes in Hispanic Hemodialysis Patients of the West vs. East Coasts of the United States. American Journal of Nephrology .41: 284-295, 2015

529. Takasu C, Vaziri ND, Li S, Robles L, Vo K, Takasu M, Pham C,. Farzaneh SH, Foster C, Stamos M, Ichii H. Treatment with Dimethyl Fumarate ameliorates calcineurin inhibitor-induced Nephrotoxicity. Transplantation 99(6):1144-50, 2015

530. Lau WL, Liu S, Pahlevan S, Yuan J, Khazaeli M, Ni Z, Chan J, Vaziri ND. Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption Digestive Disease and Sci 60(5):1215-22, 2015

531. Vaziri, ND; Liu S; Farzaneh SH; Nazertehrani S; Khazaeli, M. Dose-dependent deleterious and salutary actions of Nrf2 inducer, dh404, in chronic kidney disease. Free Radic Biol Med. 86: 374-381, 2015

532. Javkhedkar AJ, Quiroz Y, Rodriguez-Iturbe B, Vaziri ND, Lokhandwala MF, Banday AA. Resveratrol restored Nrf2 activity, reduced renal inflammation and ameliorated hypertension in the spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 308(10):R840-846, 2015

533. Ye T, Zhen J, Du Y, Zhou JK, Peng A, Vaziri ND, Mohan C, Xu Y, Zhou XJ. Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis. PLoS One. 18;10(3): e0119543. doi: 10.1371/journal.pone.0119543. eCollection, 2015

534. Pedruzzia L M., Cardozoa LF, Dalepraneb J B, Stockler-Pintoa MB, Monteirob EB, Leite M, Vaziri ND, Mafraa D. Systemic inflammation and oxidative stress in hemodialysis patients are associated with down-regulation of Nrf2. J Nephrology . 28(4):495-501, 2015

535. Miao H, Chen H, Pei S, Bai X, Vaziri ND, Zhao YY. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia. Chem Biol Interact. 25; 228:79-87, 2015

536. Masuda Y, Vaziri ND, Li S, Le A , Hajighasemi-Ossareh M, Robles L, Foster C, Stamos M, Al-Abodullah I, Ricordi C, Ichii H. The effect of Nrf2 pathway activation on human pancreatic islet cells. PLoS One. 10(6):e0131012. doi: 10.1371/journal.pone.0131012. eCollection 2015

537. Robles L, Vaziri ND, Li S, Masuda Y, Takasu C, Vo K, Farzaneh S, Stamos M, Ichii H. Dimethyl fumarate ameliorates acute pancreatitis in rodents. Pancreas 44(3):441-7, 2015

538. Zhao YY, Wang H, Chen H, Tian T, Cheng X, Wei F, Bai X, Vaziri ND. Metabolomics identifies lipid abnormalities linked to oxidative stress, inflammation, fibrosis, and Nrf2 dysfunction in aristolochic acid-induced nephropathy. Scientific Reports 7;5:12936. doi: 10.1038/srep12936, 2015

539. Zhang Z, Wei F,Vaziri ND,Cheng XL, Bai X, Lin RC, Zhao YY. Metabolomics insights into chronic kidney disease and modulatory effect of rhubarb against tubulointerstitial fibrosis. Scientific Reports 28;5:14472. doi: 10.1038/srep14472; 2015

540. Robles L, Vaziri ND, Li S, Masuda Y, Takasu C, Takasu M, Vo K, Farzaneh SH, Stamos MJ, Ichii H. Synthetic Triterpenoid RTA dh404 (CDDO-dhTFEA) Ameliorates Acute Pancreatitis. Pancreas.;45(5):720-729, 2016

541. KiefferDA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, Nazertehrani S, Moore4, Maria ME, Marco L., Martin1 R, Adams SH. Resistant Starch Alters the Gut Microbiota, Uremic Retention Solutes and Xeno-Metabolite Profiles Concurrent with Amelioration of Chronic Kidney Disease in Rats. Am J Physiol, Renal Physiol 310 (9):857-871; 2016

542. Miao H, Zhao YH, Vaziri ND., Tang DD, Chen H, Chen H, Khazaeli M, Tarbiat M, Hatami L, Zhao YY, Ma SC. Lipidomics biomarkers of diet-induced hyperlipidemia and its treatment with Poria cocos. J Agricultural and Food Chemistry 64(4):969-79, 2016

543. Zhang Z, Vaziri ND, Wei F, Cheng XL, Bai X, Zhao YY. An integrated lipidomics and metabolomics reveal nephroprotective effect and biochemical mechanism of Rheum officinale in chronic renal failure. Sci Rep 23;6:22151. doi: 10.1038/srep22151, 2016

544. Zhang X, taimer N, Gillen DL, Tjoa T, Schauer JJ, Shafer MM, Hasheminassab S, Pakbin P, Vaziri ND., Sioutas C,. Delfino RJ. Associations of oxidative stress and inflammatory biomarkers with chemically-characterized air pollutant exposures in an elderly cohort. Environmental Research 150: 306–319, 2016

545. Zhang ZH, Chen H, Vaziri ND, Miao JR, Zhang L, Bai X, Zhao YY. Metabolomic signatures of chronic kidney disease of diverse etiologies in the rats and humans. J Proteome Res. 28;10:168-178, 2016

546. Chen H, Cao G, Chen DQ, Wang M, Vaziri ND, Zhang ZH, Mao JR, Bai X, Zhao YY. Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression. Redox Biol. 28;10:168-178, 2016

547. Moradi H; Oveisi F, Khanifar E, Vaziri ND, Piomelli D. Increased Renal 2-Arachidonoylglycerol Level is Associated With Imporved Renal Function in Ischemia-Reperfusion Acute Kidney Injury. Cannabis and Cannabinoid Research 1.1, DOI: 10.1089/can.2016.0013, 2016

548. Jin KB, Vaziri ND.. Elevated plasma cyclophilin A in hemodialysis and peritoneal dialysis patients: a novel link to systemic inflammation and cardiovascular disease. IJKD. 11(1):44-49. 2016

549. Vaziri ND, Khazaeli M, Nunes ACF, Harley KT, Lau WL, Pahl MV. Blood ammonia level in ESRD patients maintained on hemodialysis and peritoneal dialysis. Hemodialysis Int. 2016 Nov 1. doi: 10.1111/hdi.12510. [Epub ahead of print], PMID: 27804262

550. Park C, Obi Y; Streja CE; Catabay C, Vaziri ND; Kovesdy CP; Kalantar-Zadeh K. Serum Uric Acid, Protein Intake, and Mortality in Hemodialysis Patients. Nephol Dial Transplant 1–8, 2017

551. Zhao YY; Chen H; Vaziri ND; Chen DQ; Zhang Z-H; Miao J-R; Zhang L; Su W; Bai X. A combined clinical phenotype and lipidomic analysis reveals the impact of chronic kidney disease on lipid metabolism. J Proteom Res (In press)

552. Zhao YY, Wei F, Cheng X, Bai X, Lin R, Vaziri ND. Activation of oxidative, inflammatory, and pro-fibrotic pathways is associated with severe lipidome and metabolome disturbances in chronic interstitial nephropathy. J Proteom Res (In press)

553. Chang TI; S Elani Streja; Soohoo M; Tae W;; Mehrotra R; Kovesdy CP; Kashyap ML; Vaziri ND. Kalantar-Zadeh Kamyar; Moradi H. Association of Serum Triglyceride to High-density lipoprotein cholesterol Ratio with Outcomes in Incident Hemodialysis Patients. CJASN (In press)

NIH and various donors.

Western Association of Physicians (President Elect) 1994-

The American Society of Hypertension, 1994-

The American Physiological Society, 1994-

Council on High Blood Pressure Research (Fellow), 1999-

American Heart Association, Kidney Council, 1985 Present

American Paraplegia Society (Past President) 1982 Present

International Society of Nephrology, 1981 Present

American Society for Artificial Internal Organs, 1979-

American Federation for Medical Research, 1978-Present

American Society of Nephrology, 1977 Present

Alpha Omega Alpha (AOA) Honor Medical,Society, 1976 Present

American College of Physicians (Master) 1975 - present

UC Irvine, Med Sci I

Link to this profile
https://faculty.uci.edu/profile/?facultyId=2994

Last updated
02/21/2017